| Year |
Citation |
Score |
| 2020 |
Hiram R, Xiong F, Naud P, Xiao J, Sirois M, Tanguay JF, Tardif JC, Nattel S. The inflammation-resolution promoting molecule resolvin-D1 prevents atrial proarrhythmic remodeling in experimental right heart disease. Cardiovascular Research. PMID 32866246 DOI: 10.1093/Cvr/Cvaa186 |
0.302 |
|
| 2020 |
Bouabdallaoui N, Tardif JC, Waters DD, Pinto FJ, Maggioni AP, Diaz R, Berry C, Koenig W, Lopez-Sendon J, Gamra H, Kiwan GS, Blondeau L, Orfanos A, Ibrahim R, Grégoire JC, et al. Time-to-treatment initiation of colchicine and cardiovascular outcomes after myocardial infarction in the Colchicine Cardiovascular Outcomes Trial (COLCOT). European Heart Journal. PMID 32860034 DOI: 10.1093/Eurheartj/Ehaa659 |
0.308 |
|
| 2020 |
Jolicoeur EM, Dendukuri N, Belisle P, Range G, Souteyrand G, Bouisset F, Zemour G, Delarche N, Harbaoui B, Schampaert E, Kouz S, Cayla G, Roubille F, Boueri Z, Mansour S, ... ... Tardif JC, et al. Immediate vs Delayed Stenting in ST-Elevation Myocardial Infarction: Rationale and Design of the International PRIMACY Bayesian Randomized Controlled Trial. The Canadian Journal of Cardiology. PMID 32798463 DOI: 10.1016/J.Cjca.2020.01.019 |
0.347 |
|
| 2020 |
Stienen S, Bhatt A, Ferreira JP, Vaduganathan M, Januzzi J, Adams K, Tardif JC, Rossignol P, Zannad F. Bias in natriuretic peptide-guided heart failure trials: time to improve guideline adherence using alternative approaches. Heart Failure Reviews. PMID 32783110 DOI: 10.1007/S10741-020-10004-6 |
0.32 |
|
| 2020 |
Legault MA, Sandoval J, Provost S, Barhdadi A, Lemieux Perreault LP, Shah S, Lumbers RT, de Denus S, Tyl B, Tardif JC, Dubé MP. A genetic model of ivabradine recapitulates results from randomized clinical trials. Plos One. 15: e0236193. PMID 32692755 DOI: 10.1371/Journal.Pone.0236193 |
0.352 |
|
| 2020 |
Busque L, Sun M, Buscarlet M, Ayachi S, Feroz Zada Y, Provost S, Bourgoin V, Mollica L, Meisel M, Hinterleitner R, Jabri B, Dubé MP, Tardif JC. High-sensitivity C-reactive protein is associated with clonal hematopoiesis of indeterminate potential. Blood Advances. 4: 2430-2438. PMID 32492156 DOI: 10.1182/Bloodadvances.2019000770 |
0.338 |
|
| 2020 |
Bouabdallaoui N, Messas N, Greenlaw N, Ferrari R, Ford I, Fox KM, Tendera M, P Naidoo D, Hassager C, Gabriel Steg P, Tardif JC. Impact of smoking on cardiovascular outcomes in patients with stable coronary artery disease. European Journal of Preventive Cardiology. 2047487320918728. PMID 32340463 DOI: 10.1177/2047487320918728 |
0.362 |
|
| 2020 |
Maguy A, Tardif JC, Busseuil D, Ribi C, Li J. Autoantibody Signature in Cardiac Arrest. Circulation. PMID 32312099 DOI: 10.1161/Circulationaha.119.044408 |
0.311 |
|
| 2020 |
Parma Z, Jasilek A, Greenlaw N, Ferrari R, Ford I, Fox K, Tardif JC, Tendera M, Steg PG. Incident heart failure in outpatients with chronic coronary syndrome: results from the international prospective CLARIFY registry. European Journal of Heart Failure. PMID 32297414 DOI: 10.1002/Ejhf.1827 |
0.349 |
|
| 2020 |
Shin SH, Claggett B, Pfeffer MA, Skali H, Liu J, Aguilar D, Diaz R, Dickstein K, Gerstein HC, Køber LV, Lawson FC, Lewis EF, Maggioni AP, McMurray JJV, Probstfield JL, ... ... Tardif JC, et al. Hyperglycaemia, ejection fraction and the risk of heart failure or cardiovascular death in patients with type 2 diabetes and a recent acute coronary syndrome. European Journal of Heart Failure. PMID 32212368 DOI: 10.1002/Ejhf.1790 |
0.353 |
|
| 2020 |
Tardif JC, Dubé MP, Pfeffer MA, Waters DD, Koenig W, Maggioni AP, McMurray JJV, Mooser V, White HD, Heinonen T, Black DM, Guertin MC. Study design of Dal-GenE, a pharmacogenetic trial targeting reduction of cardiovascular events with dalcetrapib. American Heart Journal. 222: 157-165. PMID 32087417 DOI: 10.1016/J.Ahj.2020.01.007 |
0.34 |
|
| 2020 |
Wijkman MO, Claggett B, Diaz R, Gerstein HC, Kober L, Lewis E, Maggioni AP, Wolsk E, Aguilar D, Bentley-Lewis R, Mcmurray JJ, Probstfield JL, Riddle MC, Tardif J, Solomon S, et al. 1421-P: The Impact of Blood Pressure on Risk of Death Is Influenced by Prior Cardiovascular Disease in Patients with Type 2 Diabetes and a Recent Coronary Event Diabetes. 69. DOI: 10.2337/Db20-1421-P |
0.333 |
|
| 2020 |
Zhang Z, Bhatt DL, Zhang C, Dolman S, Boden WE, Steg P, Miller M, Brinton EA, King JB, Bress AP, Jacobson TA, Tardif J, Ballantyne CM, Kolm P, Weintraub WS. Abstract 26: Scenario Analyses of Lifetime Cost-effectiveness of Icosapent Ethyl in REDUCE-IT Circulation-Cardiovascular Quality and Outcomes. 13. DOI: 10.1161/Hcq.13.Suppl_1.26 |
0.303 |
|
| 2019 |
Vidal-Petiot E, Greenlaw N, Kalra PR, Garcia-Moll X, Tardif JC, Ford I, Zamorano J, Ferrari R, Tendera M, Fox KM, Steg PG, On Behalf Of The Clarify Investigators. Chronic Kidney Disease Has a Graded Association with Death and Cardiovascular Outcomes in Stable Coronary Artery Disease: An Analysis of 21,911 Patients from the CLARIFY Registry. Journal of Clinical Medicine. 9. PMID 31861379 DOI: 10.3390/Jcm9010004 |
0.353 |
|
| 2019 |
Bhatt DL, Miller M, Brinton EA, Jacobson TA, Steg PG, Ketchum SB, Doyle RT, Juliano RA, Jiao L, Granowitz C, Tardif JC, Olshansky B, Chung MK, Gibson CM, Giugliano RP, et al. REDUCE-IT USA: Results from the 3,146 Patients Randomized in the United States. Circulation. PMID 31707829 DOI: 10.1161/Circulationaha.119.044440 |
0.336 |
|
| 2019 |
AlTurki A, Marafi M, Dawas A, Dube MP, Vieira L, Sherman MH, Gregoire J, Thanassoulis G, Tardif JC, Huynh T. Meta-analysis of Randomized Controlled Trials Assessing the Impact of Proprotein Convertase Subtilisin/Kexin Type 9 Antibodies on Mortality and Cardiovascular Outcomes. The American Journal of Cardiology. PMID 31679643 DOI: 10.1016/J.Amjcard.2019.09.011 |
0.36 |
|
| 2019 |
Bouabdallaoui N, O'Meara E, Bernier V, Komajda M, Swedberg K, Tavazzi L, Borer JS, Bohm M, Ford I, Tardif JC. Beneficial effects of ivabradine in patients with heart failure, low ejection fraction, and heart rate above 77 b.p.m. Esc Heart Failure. PMID 31591826 DOI: 10.1002/Ehf2.12513 |
0.34 |
|
| 2019 |
Sorbets E, Fox KM, Elbez Y, Danchin N, Dorian P, Ferrari R, Ford I, Greenlaw N, Kalra PR, Parma Z, Shalnova S, Tardif JC, Tendera M, Zamorano JL, Vidal-Petiot E, et al. Long-term outcomes of chronic coronary syndrome worldwide: insights from the international CLARIFY registry. European Heart Journal. PMID 31504434 DOI: 10.1093/Eurheartj/Ehz660 |
0.312 |
|
| 2019 |
Bhatt DL, Steg PG, Miller M, Brinton EA, Jacobson TA, Jiao L, Tardif JC, Gregson J, Pocock SJ, Ballantyne CM. Reduction in First and Total Ischemic Events With Icosapent Ethyl Across Baseline Triglyceride Tertiles. Journal of the American College of Cardiology. 74: 1159-1161. PMID 31439224 DOI: 10.1016/J.Jacc.2019.06.043 |
0.325 |
|
| 2019 |
Nawaito S, Sahadevan P, Clavet-Lanthier MÉ, Pouliot P, Sahmi F, Shi Y, Gillis MA, Lesage F, Gaestel M, Sirois MG, Calderone A, Tardif JC, Allen BG. MK5 haplodeficiency decreases collagen deposition and scar size during post-myocardial infarction wound repair. American Journal of Physiology. Heart and Circulatory Physiology. PMID 30901279 DOI: 10.1152/Ajpheart.00532.2017 |
0.325 |
|
| 2019 |
Gandhi S, Goodman SG, Greenlaw N, Ford I, McSkimming P, Ferrari R, Jang Y, Alcocer-Gamba MA, Fox K, Tardif JC, Tendera M, Dorian P, Steg G, Udell JA. Living alone and cardiovascular disease outcomes. Heart (British Cardiac Society). PMID 30792241 DOI: 10.1136/Heartjnl-2018-313844 |
0.327 |
|
| 2019 |
Jang JJ, Bhapkar M, Coles A, Vemulapalli S, Fordyce CB, Lee KL, Udelson JE, Hoffmann U, Tardif JC, Jones WS, Mark DB, Sorrell VL, Espinoza A, Douglas PS, Patel MR, et al. Predictive Model for High-Risk Coronary Artery Disease. Circulation. Cardiovascular Imaging. 12: e007940. PMID 30712364 DOI: 10.1161/Circimaging.118.007940 |
0.347 |
|
| 2019 |
Januzzi JL, Suchindran S, Hoffmann U, Patel MR, Ferencik M, Coles A, Tardif JC, Ginsburg GS, Douglas PS. Single-Molecule hsTnI and Short-Term Risk in Stable Patients With Chest Pain. Journal of the American College of Cardiology. 73: 251-260. PMID 30678753 DOI: 10.1016/J.Jacc.2018.10.065 |
0.333 |
|
| 2018 |
Huynh T, Lecca P, Montigny M, Gagnon R, Eisenberg MJ, Lauzon C, Mansour S, Rinfret S, Afilalo M, Nguyen M, Kouz S, Dery JP, Harvey R, Schampaert E, Tardif JC. Ten-Year Statin Adherence in Survivors of ST-Segment Elevation Myocardial Infarction. Journal of Population Therapeutics and Clinical Pharmacology = Journal De La Therapeutique Des Populations Et De La Pharamcologie Clinique. 25: e63-e77. PMID 30725543 DOI: 10.22374/1710-6222.25.2.5 |
0.302 |
|
| 2018 |
Sorbets E, Steg PG, Young R, Danchin N, Greenlaw N, Ford I, Tendera M, Ferrari R, Merkely B, Parkhomenko A, Reid C, Tardif JC, Fox KM. β-blockers, calcium antagonists, and mortality in stable coronary artery disease: an international cohort study. European Heart Journal. PMID 30590529 DOI: 10.1093/Eurheartj/Ehy811 |
0.321 |
|
| 2018 |
Pfeffer MA, Tardif JC. COMMANDER HF - A Trial and an Answer. The New England Journal of Medicine. 379: 1372-1374. PMID 30281980 DOI: 10.1056/Nejme1811089 |
0.33 |
|
| 2018 |
Couture EL, Farand P, Nguyen M, Allard C, Wells GA, Mansour S, Rinfret S, Afilalo J, Eisenberg M, Montigny M, Kouz S, Afilalo M, Lauzon C, Dery JP, L'Allier P, ... ... Tardif JC, et al. Impact of an invasive strategy in the elderly hospitalized with acute coronary syndrome with emphasis on the nonagenarians. Catheterization and Cardiovascular Interventions : Official Journal of the Society For Cardiac Angiography & Interventions. PMID 30269415 DOI: 10.1002/Ccd.27877 |
0.301 |
|
| 2018 |
Carballo D, Noble S, Carballo S, Stirnemann J, Muller H, Burri H, Vuilleumier N, Talajic M, Tardif JC, Keller PF, Mach F, Shah D. Biomarkers and arrhythmia recurrence following radiofrequency ablation of atrial fibrillation. The Journal of International Medical Research. 300060518793807. PMID 30178684 DOI: 10.1177/0300060518793807 |
0.306 |
|
| 2018 |
Vidal-Petiot E, Sorbets E, Bhatt DL, Ducrocq G, Elbez Y, Ferrari R, Ford I, Tardif JC, Tendera M, Fox KM, Steg PG. Potential impact of the 2017 ACC/AHA guideline on high blood pressure in normotensive patients with stable coronary artery disease: insights from the CLARIFY registry. European Heart Journal. PMID 30124796 DOI: 10.1093/Eurheartj/Ehy488 |
0.363 |
|
| 2018 |
Surinkaew S, Aflaki M, Takawale A, Chen Y, Qi XY, Gillis MA, Shi YF, Tardif JC, Chattipakorn N, Nattel S. Exchange-protein activated by cyclic-AMP (EPAC) regulates atrial fibroblast function and controls cardiac remodeling. Cardiovascular Research. PMID 30016400 DOI: 10.1093/Cvr/Cvy173 |
0.305 |
|
| 2018 |
Legault MA, Tardif JC, Dubé MP. Pharmacogenomics of blood lipid regulation. Pharmacogenomics. PMID 29706123 DOI: 10.2217/Pgs-2018-0007 |
0.32 |
|
| 2018 |
Denus S, Dubé MP, Fouodjio R, Huynh T, LeBlanc MH, Lepage S, Sheppard R, Giannetti N, Lavoie J, Mansour A, Provost S, Normand V, Mongrain I, Langlois M, O'Meara E, ... ... Tardif JC, et al. A prospective study of the impact of AGTR1 A1166C on the effects of candesartan in patients with heart failure. Pharmacogenomics. PMID 29701105 DOI: 10.2217/Pgs-2018-0004 |
0.317 |
|
| 2018 |
Ridker PM, Rose LM, Kastelein JJP, Santos RD, Wei C, Revkin J, Yunis C, Tardif JC, Shear CL. Cardiovascular event reduction with PCSK9 inhibition among 1578 patients with familial hypercholesterolemia: Results from the SPIRE randomized trials of bococizumab. Journal of Clinical Lipidology. PMID 29685591 DOI: 10.1016/J.Jacl.2018.03.088 |
0.303 |
|
| 2018 |
Rautureau Y, Deschambault V, Higgins MÈ, Rivas D, Mecteau M, Geoffroy P, Miquel G, Uy K, Sanchez R, Lavoie V, Brand G, Nault A, Williams PM, Suarez ML, Merlet N, ... ... Tardif JC, et al. Adenylate Cyclase Type 9 (ADCY9) Inactivation Protects from Atherosclerosis Only in the Absence of Cholesteryl Ester Transfer Protein (CETP). Circulation. PMID 29674325 DOI: 10.1161/Circulationaha.117.031134 |
0.306 |
|
| 2018 |
Huynh T, Montigny M, Iftikhar U, Gagnon R, Eisenberg M, Lauzon C, Mansour S, Rinfret S, Afilalo M, Nguyen M, Kouz S, Déry JP, Harvey R, De LaRocheliere R, Cantin B, ... ... Tardif JC, et al. Recurrent Cardiovascular Events in Survivors of Myocardial Infarction With ST-Segment Elevation (from the AMI-QUEBEC Study). The American Journal of Cardiology. PMID 29452691 DOI: 10.1016/J.Amjcard.2017.12.037 |
0.354 |
|
| 2018 |
Dayeh NR, Tardif JC, Shi Y, Tanguay M, Ledoux J, Dupuis J. Echocardiographic validation of pulmonary hypertension due to heart failure with reduced ejection fraction in mice. Scientific Reports. 8: 1363. PMID 29358732 DOI: 10.1038/S41598-018-19625-2 |
0.311 |
|
| 2017 |
Himmelfarb J, Chertow GM, McCullough PA, Mesana T, Shaw AD, Sundt TM, Brown C, Cortville D, Dagenais F, de Varennes B, Fontes M, Rossert J, Tardif JC. Perioperative THR-184 and AKI after Cardiac Surgery. Journal of the American Society of Nephrology : Jasn. PMID 29203473 DOI: 10.1681/Asn.2017020217 |
0.311 |
|
| 2017 |
Vidal-Petiot E, Greenlaw N, Ford I, Ferrari R, Fox KM, Tardif JC, Tendera M, Parkhomenko A, Bhatt DL, Steg PG. Relationships Between Components of Blood Pressure and Cardiovascular Events in Patients with Stable Coronary Artery Disease and Hypertension. Hypertension (Dallas, Tex. : 1979). PMID 29084876 DOI: 10.1161/Hypertensionaha.117.10204 |
0.361 |
|
| 2017 |
Liu DJ, Peloso GM, Yu H, Butterworth AS, Wang X, Mahajan A, Saleheen D, Emdin C, Alam D, Alves AC, Amouyel P, Di Angelantonio E, Arveiler D, Assimes TL, Auer PL, ... ... Tardif JC, et al. Exome-wide association study of plasma lipids in >300,000 individuals. Nature Genetics. PMID 29083408 DOI: 10.1038/Ng.3977 |
0.303 |
|
| 2017 |
Wolsk E, Claggett B, Diaz R, Dickstein K, Gerstein HC, Køber L, Lawson FC, Lewis EF, Maggioni AP, McMurray JJV, Probstfield JL, Riddle MC, Solomon SD, Tardif JC, Pfeffer MA. Increases in Natriuretic Peptides Precede Heart Failure Hospitalization in Patients With a Recent Coronary Event and Type 2 Diabetes Mellitus. Circulation. 136: 1560-1562. PMID 29038210 DOI: 10.1161/Circulationaha.117.029503 |
0.364 |
|
| 2017 |
Messas N, Dubé MP, Tardif JC. Pharmacogenetics of Lipid-Lowering Agents: an Update Review on Genotype-Dependent Effects of HDL-Targetingand Statin Therapies. Current Atherosclerosis Reports. 19: 43. PMID 28944433 DOI: 10.1007/S11883-017-0679-5 |
0.303 |
|
| 2017 |
Rosenson RS, Brewer HB, Barter PJ, Björkegren JLM, Chapman MJ, Gaudet D, Kim DS, Niesor E, Rye KA, Sacks FM, Tardif JC, Hegele RA. HDL and atherosclerotic cardiovascular disease: genetic insights into complex biology. Nature Reviews. Cardiology. PMID 28795686 DOI: 10.1038/Nrcardio.2017.115 |
0.308 |
|
| 2017 |
Nolte IM, Munoz ML, Tragante V, Amare AT, Jansen R, Vaez A, von der Heyde B, Avery CL, Bis JC, Dierckx B, van Dongen J, Gogarten SM, Goyette P, Hernesniemi J, Huikari V, ... ... Tardif JC, et al. Erratum: Genetic loci associated with heart rate variability and their effects on cardiac disease risk. Nature Communications. 8: 16140. PMID 28767105 DOI: 10.1038/Ncomms16140 |
0.31 |
|
| 2017 |
Sorbets E, Greenlaw N, Ferrari R, Ford I, Fox KM, Tardif JC, Tendera M, Steg PG. Rationale, design, and baseline characteristics of the CLARIFY registry of outpatients with stable coronary artery disease. Clinical Cardiology. PMID 28561986 DOI: 10.1002/Clc.22730 |
0.357 |
|
| 2017 |
Wolsk E, Claggett B, Pfeffer MA, Diaz R, Dickstein K, Gerstein HC, Lawson FC, Lewis EF, Maggioni AP, McMurray JJV, Probstfield JL, Riddle MC, Solomon SD, Tardif JC, Køber L. Role of B-Type Natriuretic Peptide and N-Terminal Prohormone BNP as Predictors of Cardiovascular Morbidity and Mortality in Patients With a Recent Coronary Event and Type 2 Diabetes Mellitus. Journal of the American Heart Association. 6. PMID 28554908 DOI: 10.1161/Jaha.116.004743 |
0.326 |
|
| 2017 |
Pagiatakis C, Tardif JC, L'Allier PL, Mongrain R. Effect of stenosis eccentricity on the functionality of coronary bifurcation lesions-a numerical study. Medical & Biological Engineering & Computing. PMID 28500478 DOI: 10.1007/S11517-017-1653-7 |
0.341 |
|
| 2017 |
Nawaito S, Dingar D, Sahadevan P, Hussein B, Sahmi F, Shi Y, Gillis MA, Gaestel M, Tardif JC, Allen BG. MK5 haplodefficiency attenuates hypertrophy and preserves diastolic function during remodeling induced by chronic pressure overload in the mouse heart. American Journal of Physiology. Heart and Circulatory Physiology. ajpheart.00597.2016. PMID 28432058 DOI: 10.1152/Ajpheart.00597.2016 |
0.313 |
|
| 2017 |
Hoffmann U, Ferencik M, Udelson JE, Picard MH, Truong QA, Patel MR, Huang M, Pencina MJ, Mark DB, Heitner JF, Fordyce CB, Pellikka PA, Tardif JC, Budoff MJ, Nahhas G, et al. Prognostic Value of Noninvasive Cardiovascular Testing in Patients with Stable Chest Pain: Insights from the PROMISE Trial. Circulation. PMID 28389572 DOI: 10.1161/Circulationaha.116.024360 |
0.349 |
|
| 2017 |
Ridker PM, Revkin J, Amarenco P, Brunell R, Curto M, Civeira F, Flather M, Glynn RJ, Gregoire J, Jukema JW, Karpov Y, Kastelein JJ, Koenig W, Lorenzatti A, Manga P, ... ... Tardif JC, et al. Cardiovascular Efficacy and Safety of Bococizumab in High-Risk Patients. The New England Journal of Medicine. PMID 28304242 DOI: 10.1056/Nejmoa1701488 |
0.346 |
|
| 2017 |
Bhatt DL, Steg PG, Brinton EA, Jacobson TA, Miller M, Tardif JC, Ketchum SB, Doyle RT, Murphy SA, Soni PN, Braeckman RA, Juliano RA, Ballantyne CM. Rationale and design of REDUCE-IT: Reduction of Cardiovascular Events with Icosapent Ethyl-Intervention Trial. Clinical Cardiology. PMID 28294373 DOI: 10.1002/Clc.22692 |
0.362 |
|
| 2017 |
Parkash R, Wells GA, Sapp JL, Healey JS, Tardif JC, Greiss I, Rivard L, Roux JF, Gula L, Nault I, Novak PG, Birnie DH, Ha AC, Wilton SB, Mangat I, et al. The Effect of Aggressive Blood Pressure Control on the Recurrence of Atrial Fibrillation After Catheter Ablation: A Randomized, Open Label, Clinical Trial (Substrate Modification with Aggressive Blood Pressure Control: SMAC- AF). Circulation. PMID 28228428 DOI: 10.1161/Circulationaha.116.026230 |
0.303 |
|
| 2017 |
Parma Z, Steg PG, Greenlaw N, Ferrari R, Ford I, Fox K, Tardif JC, Morais J, Gamba MA, Kääb S, Tendera M. Differences in outcomes in patients with stable coronary artery disease managed by cardiologists versus non-cardiologists: the international prospective CLARIFY registry. Polskie Archiwum Medycyny Wewnetrznej. PMID 28224974 DOI: 10.20452/Pamw.3902 |
0.36 |
|
| 2017 |
van Diepen S, Merrill PD, Carrier M, Tardif JC, Podgoreanu M, Alexander JH, Lopes RD. Association between CK-MB Area Under the Curve and Tranexamic Acid Utilization in Patients Undergoing Coronary Artery Bypass Surgery. Journal of Thrombosis and Thrombolysis. PMID 28194628 DOI: 10.1007/S11239-017-1480-6 |
0.381 |
|
| 2017 |
van Steen SC, Schrieks IC, Hoekstra JB, Lincoff AM, Tardif JC, Mellbin LG, Rydén L, Grobbee DE, DeVries JH. The haemoglobin glycation index as predictor of diabetes-related complications in the AleCardio trial. European Journal of Preventive Cardiology. 2047487317692664. PMID 28186441 DOI: 10.1177/2047487317692664 |
0.323 |
|
| 2017 |
Tardif JC, Rhainds D, Rhéaume E, Dubé MP. CETP: Pharmacogenomics-Based Response to the CETP Inhibitor Dalcetrapib. Arteriosclerosis, Thrombosis, and Vascular Biology. PMID 28126828 DOI: 10.1161/Atvbaha.116.307122 |
0.348 |
|
| 2017 |
Kalra PR, Greenlaw N, Ferrari R, Ford I, Tardif JC, Tendera M, Reid CM, Danchin N, Stepinska J, Steg PG, Fox KM. Hemoglobin and Change in Hemoglobin Status Predict Mortality, Cardiovascular Events and Bleeding in Stable Coronary Artery Disease. The American Journal of Medicine. PMID 28109968 DOI: 10.1016/J.Amjmed.2017.01.002 |
0.364 |
|
| 2017 |
Destrempes F, Roy Cardinal MH, Saijo Y, Finet G, Tardif JC, Cloutier G. Assessment of Inter-Expert Variability and of an Automated Segmentation Method of 40 and 60 MHz IVUS Images of Coronary Arteries. Plos One. 12: e0168332. PMID 28107355 DOI: 10.1371/Journal.Pone.0168332 |
0.306 |
|
| 2017 |
Gebhard C, Rhéaume E, Berry C, Brand G, Kernaleguen AE, Théberge-Julien G, Alam MA, Lee CY, Boileau L, Chabot-Blanchet M, Guertin MC, Lavoie MA, Grégoire J, Ibrahim R, L'Allier P, ... Tardif JC, et al. Beneficial Effects of Reconstituted High-Density Lipoprotein (rHDL) on Circulating CD34+ Cells in Patients after an Acute Coronary Syndrome. Plos One. 12: e0168448. PMID 28060837 DOI: 10.1371/Journal.Pone.0168448 |
0.321 |
|
| 2016 |
Bertrand MJ, Tardif JC. Inflammation and beyond: New directions and emerging drugs for treating atherosclerosis. Expert Opinion On Emerging Drugs. PMID 27927063 DOI: 10.1080/14728214.2017.1269743 |
0.348 |
|
| 2016 |
de Souza Brito F, Mehta RH, Lopes RD, Harskamp RE, Lucas BD, Schulte PJ, Tardif JC, Alexander JH. Non-Steroidal Anti-Inflammatory Drugs and Clinical Outcomes in Patients Undergoing Coronary Artery Bypass Surgery. The American Journal of Medicine. PMID 27888052 DOI: 10.1016/J.Amjmed.2016.10.023 |
0.326 |
|
| 2016 |
Matsumoto S, Ibrahim R, Grégoire JC, L'Allier PL, Pressacco J, Tardif JC, Budoff MJ. Effect of treatment with 5-lipoxygenase inhibitor VIA-2291 (atreleuton) on coronary plaque progression: a serial CT angiography study. Clinical Cardiology. PMID 27883201 DOI: 10.1002/Clc.22646 |
0.324 |
|
| 2016 |
Vidal-Petiot E, Ford I, Greenlaw N, Ferrari R, Fox KM, Tardif JC, Tendera M, Tavazzi L, Bhatt DL, Steg PG. Cardiovascular event rates and mortality according to achieved systolic and diastolic blood pressure in patients with stable coronary artery disease: an international cohort study. Lancet (London, England). PMID 27590221 DOI: 10.1016/S0140-6736(16)31326-5 |
0.345 |
|
| 2016 |
Asgar AW, Khairy P, Guertin MC, Cournoyer D, Ducharme A, Bonan R, Basmadjian A, Tardif JC, Cohen DJ. Clinical outcomes and economic impact of transcatheter mitral leaflet repair in heart failure patients. Journal of Medical Economics. 1-27. PMID 27552378 DOI: 10.1080/13696998.2016.1227828 |
0.327 |
|
| 2016 |
Vaillant F, Lauzier B, Ruiz M, Shi Y, Lachance D, Rivard ME, Bolduc V, Thorin E, Tardif JC, Des Rosiers C. Ivabradine and metoprolol differentially affect cardiac glucose metabolism despite similar heart rate reduction in a mouse model of dyslipidemia. American Journal of Physiology. Heart and Circulatory Physiology. ajpheart.00789.2015. PMID 27496881 DOI: 10.1152/Ajpheart.00789.2015 |
0.33 |
|
| 2016 |
Denault AY, Bussières JS, Arellano R, Finegan B, Gavra P, Haddad F, Nguyen AQ, Varin F, Fortier A, Levesque S, Shi Y, Elmi-Sarabi M, Tardif JC, Perrault LP, Lambert J. A multicentre randomized-controlled trial of inhaled milrinone in high-risk cardiac surgical patients. Canadian Journal of Anaesthesia = Journal Canadien D'Anesthesie. PMID 27470232 DOI: 10.1007/S12630-016-0709-8 |
0.324 |
|
| 2016 |
Anand SS, Tu JV, Awadalla P, Black S, Boileau C, Busseuil D, Desai D, Després JP, de Souza RJ, Dummer T, Jacquemont S, Knoppers B, Larose E, Lear SA, Marcotte F, ... ... Tardif JC, et al. Rationale, design, and methods for Canadian alliance for healthy hearts and minds cohort study (CAHHM) - a Pan Canadian cohort study. Bmc Public Health. 16: 650. PMID 27464510 DOI: 10.1186/S12889-016-3310-8 |
0.317 |
|
| 2016 |
Henri C, O'Meara E, De Denus S, Elzir L, Tardif JC. Ivabradine for the treatment of chronic heart failure. Expert Review of Cardiovascular Therapy. 14: 553-61. PMID 26967048 DOI: 10.1586/14779072.2016.1165092 |
0.331 |
|
| 2016 |
Stähli BE, Tardif JC, Carrier M, Gallo R, Emery RW, Robb S, Cournoyer D, Blondeau L, Johnson D, Mann J, Lespérance J, Guertin MC, L'Allier PL. Effects of P-Selectin Antagonist Inclacumab in Patients Undergoing Coronary Artery Bypass Graft Surgery: SELECT-CABG Trial. Journal of the American College of Cardiology. 67: 344-6. PMID 26796402 DOI: 10.1016/J.Jacc.2015.10.071 |
0.332 |
|
| 2016 |
Stitziel NO, Stirrups KE, Masca NGD, Erdmann J, Ferrario PG, Koenig IR, Weeke PE, Webb TR, Auer PL, Schick UM, Lu Y, Zhang H, Dube M, Goel A, Farrall M, ... ... Tardif J, et al. Coding Variation in ANGPTL4, LPL, and SVEP1 and the Risk of Coronary Disease (vol 374, pg 1134, 2016) The New England Journal of Medicine. 374: 1898-1898. DOI: 10.17863/Cam.15756 |
0.304 |
|
| 2015 |
Andrade JG, Roy D, Wyse DG, Tardif JC, Talajic M, Leduc H, Tourigny JC, Shohoudi A, Dubuc M, Rivard L, Guerra PG, Thibault B, Dyrda K, Macle L, Khairy P. Heart rate and adverse outcomes in patients with atrial fibrillation: A combined AFFIRM and AF-CHF substudy. Heart Rhythm : the Official Journal of the Heart Rhythm Society. PMID 26299677 DOI: 10.1016/J.Hrthm.2015.08.028 |
0.335 |
|
| 2015 |
Mancini GB, Howlett JG, Borer J, Liu PP, Mehra MR, Pfeffer M, Swedberg K, Tardif JC. Pharmacologic Options for the Management of Systolic Heart Failure: Examining Underlying Mechanisms. The Canadian Journal of Cardiology. PMID 26095932 DOI: 10.1016/J.Cjca.2015.02.013 |
0.323 |
|
| 2015 |
Denault AY, Couture P, Beaulieu Y, Haddad F, Deschamps A, Nozza A, Pagé P, Tardif JC, Lambert J. Right Ventricular Depression After Cardiopulmonary Bypass for Valvular Surgery. Journal of Cardiothoracic and Vascular Anesthesia. PMID 25976606 DOI: 10.1053/J.Jvca.2015.01.011 |
0.34 |
|
| 2015 |
Bentley-Lewis R, Aguilar D, Riddle MC, Claggett B, Diaz R, Dickstein K, Gerstein HC, Johnston P, Køber LV, Lawson F, Lewis EF, Maggioni AP, McMurray JJ, Ping L, Probstfield JL, ... ... Tardif JC, et al. Rationale, design, and baseline characteristics in Evaluation of LIXisenatide in Acute Coronary Syndrome, a long-term cardiovascular end point trial of lixisenatide versus placebo. American Heart Journal. 169: 631-638.e7. PMID 25965710 DOI: 10.1016/J.Ahj.2015.02.002 |
0.352 |
|
| 2015 |
Khan R, Spagnoli V, Tardif JC, L'Allier PL. Novel anti-inflammatory therapies for the treatment of atherosclerosis. Atherosclerosis. 240: 497-509. PMID 25917947 DOI: 10.1016/J.Atherosclerosis.2015.04.783 |
0.316 |
|
| 2015 |
Fauchier L, Greenlaw N, Ferrari R, Ford I, Fox KM, Tardif JC, Tendera M, Steg PG. Use of Anticoagulants and Antiplatelet Agents in Stable Outpatients with Coronary Artery Disease and Atrial Fibrillation. International CLARIFY Registry. Plos One. 10: e0125164. PMID 25915904 DOI: 10.1371/Journal.Pone.0125164 |
0.388 |
|
| 2015 |
Beaudoin M, Gupta RM, Won HH, Lo KS, Do R, Henderson CA, Lavoie-St-Amour C, Langlois S, Rivas D, Lehoux S, Kathiresan S, Tardif JC, Musunuru K, Lettre G. Myocardial Infarction-Associated SNP at 6p24 Interferes With MEF2 Binding and Associates With PHACTR1 Expression Levels in Human Coronary Arteries. Arteriosclerosis, Thrombosis, and Vascular Biology. 35: 1472-9. PMID 25838425 DOI: 10.1161/Atvbaha.115.305534 |
0.327 |
|
| 2015 |
Gaztanaga J, Farkouh M, Rudd JH, Brotz TM, Rosenbaum D, Mani V, Kerwin TC, Taub R, Tardif JC, Tawakol A, Fayad ZA. A phase 2 randomized, double-blind, placebo-controlled study of the effect of VIA-2291, a 5-lipoxygenase inhibitor, on vascular inflammation in patients after an acute coronary syndrome. Atherosclerosis. 240: 53-60. PMID 25752438 DOI: 10.1016/J.Atherosclerosis.2015.02.027 |
0.343 |
|
| 2015 |
Gebhard C, Rhainds D, Tardif J. HDL and cardiovascular risk: is cholesterol in particle subclasses relevant? European Heart Journal. 36: 10-12. PMID 25148836 DOI: 10.1093/Eurheartj/Ehu306 |
0.33 |
|
| 2015 |
Gayda M, Juneau M, Tardif JC, Harel F, Levesque S, Nigam A. Cardiometabolic and traditional cardiovascular risk factors and their potential impact on macrovascular and microvascular function: preliminary data. Clinical Hemorheology and Microcirculation. 59: 53-65. PMID 24518371 DOI: 10.3233/Ch-141816 |
0.361 |
|
| 2015 |
Huynh T, Gagnon R, Iftikhar U, Rinfret S, Mansour S, Montigny M, Afilalo M, Kouz S, Lauzon C, Nguyen M, Harvey R, Eisenberg M, L'Allier P, Tardif J, Schampaert E. Longterm Recurrent Ischemic Cardiovascular Events Among Patients With St-Segment Elevation Myocardial Infarction: Insights From The Ami-Québec Registry Canadian Journal of Cardiology. 31. DOI: 10.1016/J.Cjca.2015.07.144 |
0.322 |
|
| 2014 |
Nattel S, Talajic M, Tardif JC. A look into the future of cardiology: perspectives from the Montreal Heart Institute. The Canadian Journal of Cardiology. 30: S399-400. PMID 25530087 DOI: 10.1016/J.Cjca.2014.10.006 |
0.346 |
|
| 2014 |
Denault AY, Beaulieu Y, Couture P, Haddad F, Shi Y, Pagé P, Levesque S, Tardif JC, Lambert J. Acute intraoperative effect of intravenous amiodarone on right ventricular function in patients undergoing valvular surgery. European Heart Journal. Acute Cardiovascular Care. PMID 25178692 DOI: 10.1177/2048872614549102 |
0.338 |
|
| 2014 |
Fox K, Ford I, Steg PG, Tardif JC, Tendera M, Ferrari R. Ivabradine in stable coronary artery disease without clinical heart failure. The New England Journal of Medicine. 371: 1091-9. PMID 25176136 DOI: 10.1056/Nejmoa1406430 |
0.422 |
|
| 2014 |
Steg PG, Greenlaw N, Tendera M, Tardif JC, Ferrari R, Al-Zaibag M, Dorian P, Hu D, Shalnova S, Sokn FJ, Ford I, Fox KM. Prevalence of anginal symptoms and myocardial ischemia and their effect on clinical outcomes in outpatients with stable coronary artery disease: data from the International Observational CLARIFY Registry. Jama Internal Medicine. 174: 1651-9. PMID 25110899 DOI: 10.1001/Jamainternmed.2014.3773 |
0.354 |
|
| 2014 |
Li J, Maguy A, Duverger JE, Vigneault P, Comtois P, Shi Y, Tardif JC, Thomas D, Nattel S. Induced KCNQ1 autoimmunity accelerates cardiac repolarization in rabbits: potential significance in arrhythmogenesis and antiarrhythmic therapy. Heart Rhythm : the Official Journal of the Heart Rhythm Society. 11: 2092-100. PMID 25087487 DOI: 10.1016/J.Hrthm.2014.07.040 |
0.316 |
|
| 2014 |
Kalra PR, García-Moll X, Zamorano J, Kalra PA, Fox KM, Ford I, Ferrari R, Tardif JC, Tendera M, Greenlaw N, Steg PG. Impact of chronic kidney disease on use of evidence-based therapy in stable coronary artery disease: a prospective analysis of 22,272 patients. Plos One. 9: e102335. PMID 25051258 DOI: 10.1371/Journal.Pone.0102335 |
0.362 |
|
| 2014 |
O'Meara E, Rouleau JL, White M, Roy K, Blondeau L, Ducharme A, Neagoe PE, Sirois MG, Lavoie J, Racine N, Liszkowski M, Madore F, Tardif JC, de Denus S. Heart failure with anemia: novel findings on the roles of renal disease, interleukins, and specific left ventricular remodeling processes. Circulation. Heart Failure. 7: 773-81. PMID 25027873 DOI: 10.1161/Circheartfailure.114.001100 |
0.353 |
|
| 2014 |
Pankert M, L'Allier PL, Tardif J. Transient right internal thoracic arterial graft kink related to respiratory movements: documentation of its existence, relevance and proposed management. Catheterization and Cardiovascular Interventions. 83: 924-928. PMID 24867627 DOI: 10.1002/Ccd.25220 |
0.325 |
|
| 2014 |
Tardif JC, Ballantyne CM, Barter P, Dasseux JL, Fayad ZA, Guertin MC, Kastelein JJ, Keyserling C, Klepp H, Koenig W, L'Allier PL, Lespérance J, Lüscher TF, Paolini JF, Tawakol A, et al. Effects of the high-density lipoprotein mimetic agent CER-001 on coronary atherosclerosis in patients with acute coronary syndromes: a randomized trial. European Heart Journal. 35: 3277-86. PMID 24780501 DOI: 10.1093/Eurheartj/Ehu171 |
0.354 |
|
| 2014 |
Boisclair Demarble J, Moskowitz DS, Tardif JC, D'Antono B. The relation between hostility and concurrent levels of inflammation is sex, age, and measure dependent. Journal of Psychosomatic Research. 76: 384-93. PMID 24745780 DOI: 10.1016/J.Jpsychores.2014.02.010 |
0.314 |
|
| 2014 |
Arsenault BJ, Boekholdt SM, Mora S, DeMicco DA, Bao W, Tardif JC, Amarenco P, Pedersen T, Barter P, Waters DD. Impact of high-dose atorvastatin therapy and clinical risk factors on incident aortic valve stenosis in patients with cardiovascular disease (from TNT, IDEAL, and SPARCL). The American Journal of Cardiology. 113: 1378-82. PMID 24582532 DOI: 10.1016/J.Amjcard.2014.01.414 |
0.335 |
|
| 2014 |
Asselin C, Ducharme A, Ntimbane T, Ruiz M, Fortier A, Guertin MC, Lavoie J, Diaz A, Levy E, Tardif JC, Des Rosiers C. Circulating levels of linoleic acid and HDL-cholesterol are major determinants of 4-hydroxynonenal protein adducts in patients with heart failure. Redox Biology. 2: 148-55. PMID 24494189 DOI: 10.1016/J.Redox.2013.12.009 |
0.311 |
|
| 2014 |
Abdelali M, Reiter S, Mongrain R, Bertrand M, L'Allier PL, Kritikou EA, Tardif JC. Cap buckling as a potential mechanism of atherosclerotic plaque vulnerability. Journal of the Mechanical Behavior of Biomedical Materials. 32: 210-24. PMID 24491969 DOI: 10.1016/J.Jmbbm.2013.12.020 |
0.326 |
|
| 2014 |
Gebhard C, Tardif J. Vitamin C and percutaneous coronary intervention: some answers, more questions. Canadian Journal of Cardiology. 30: 3-5. PMID 24365188 DOI: 10.1016/J.Cjca.2013.10.018 |
0.373 |
|
| 2014 |
Arsenault BJ, Dubé MP, Brodeur MR, de Oliveira Moraes AB, Lavoie V, Kernaleguen AE, Guauque-Olarte S, Mathieu P, Pibarot P, Messika-Zeitoun D, Bossé Y, Rhainds D, Rhéaume E, Tardif JC. Evaluation of links between high-density lipoprotein genetics, functionality, and aortic valve stenosis risk in humans. Arteriosclerosis, Thrombosis, and Vascular Biology. 34: 457-62. PMID 24334872 DOI: 10.1161/Atvbaha.113.302730 |
0.34 |
|
| 2014 |
Gandhi S, Dorian P, Greenlaw N, Tardif JC, Steg PG, Huynh T, Wong GC, Love MP, Poirier P, Goodman SG. Characteristics and evidence-based management of stable coronary artery disease patients in Canada compared with the rest of the world: insights from the CLARIFY registry. The Canadian Journal of Cardiology. 30: 132-7. PMID 24238756 DOI: 10.1016/J.Cjca.2013.07.680 |
0.375 |
|
| 2014 |
Roubille F, Busseuil D, Merlet N, Kritikou EA, Rhéaume E, Tardif J. Investigational drugs targeting cardiac fibrosis Expert Review of Cardiovascular Therapy. 12: 111-125. PMID 24218990 DOI: 10.1586/14779072.2013.839942 |
0.331 |
|
| 2014 |
Gebhard C, L'Allier PL, Tardif J. Near-infrared spectroscopy for cardiovascular risk assessment? Not ready for prime time European Heart Journal. 35: 263-265. PMID 24052602 DOI: 10.1093/Eurheartj/Eht361 |
0.389 |
|
| 2014 |
Elzir L, O’Meara E, Denus Sd, Tardif J. Ivabradine for the treatment of heart failure Clinical Investigation. 4: 555-565. DOI: 10.4155/Cli.14.36 |
0.329 |
|
| 2013 |
Chow BJ, Green RE, Coyle D, Laine M, Hanninen H, Leskinen H, Rajda M, Larose E, Hartikainen J, Hedman M, Mielniczuk L, O'Meara E, deKemp RA, Klein R, Paterson I, ... ... Tardif JC, et al. Computed tomographic coronary angiography for patients with heart failure (CTA-HF): a randomized controlled trial (IMAGE HF Project 1-C). Trials. 14: 443. PMID 24369097 DOI: 10.1186/1745-6215-14-443 |
0.406 |
|
| 2013 |
Paterson I, Wells GA, Ezekowitz JA, White JA, Friedrich MG, Mielniczuk LM, O'Meara E, Chow B, DeKemp RA, Klein R, Dennie C, Dick A, Coyle D, Dwivedi G, Rajda M, ... ... Tardif JC, et al. Routine versus selective cardiac magnetic resonance in non-ischemic heart failure - OUTSMART-HF: study protocol for a randomized controlled trial (IMAGE-HF (heart failure) project 1-B). Trials. 14: 332. PMID 24119686 DOI: 10.1186/1745-6215-14-332 |
0.325 |
|
| 2013 |
Fox K, Ford I, Steg PG, Tardif JC, Tendera M, Ferrari R. Rationale, design, and baseline characteristics of the Study assessInG the morbidity-mortality beNefits of the If inhibitor ivabradine in patients with coronarY artery disease (SIGNIFY trial): a randomized, double-blind, placebo-controlled trial of ivabradine in patients with stable coronary artery disease without clinical heart failure. American Heart Journal. 166: 654-661.e6. PMID 24093844 DOI: 10.1016/J.Ahj.2013.06.024 |
0.418 |
|
| 2013 |
Roubille F, Tournoux F, Roubille C, Merlet N, Davy J, Rhéaume E, Busseuil D, Tardif J. Management of pericarditis and myocarditis: could heart-rate-reducing drugs hold a promise? Archives of Cardiovascular Diseases. 106: 672-679. PMID 24070595 DOI: 10.1016/J.Acvd.2013.06.047 |
0.323 |
|
| 2013 |
Lincoff AM, Tardif JC, Neal B, Nicholls SJ, Rydén L, Schwartz GG, Malmberg K, Buse JB, Henry RR, Wedel H, Weichert A, Cannata R, Grobbee DE. Evaluation of the dual peroxisome proliferator-activated receptor α/γ agonist aleglitazar to reduce cardiovascular events in patients with acute coronary syndrome and type 2 diabetes mellitus: rationale and design of the AleCardio trial. American Heart Journal. 166: 429-34. PMID 24016490 DOI: 10.1016/J.Ahj.2013.05.013 |
0.334 |
|
| 2013 |
Tardif JC, Grégoire J. Renin-angiotensin system inhibition and secondary cardiovascular prevention. Jama. 310: 1130-1. PMID 23999917 DOI: 10.1001/Jama.2013.277170 |
0.42 |
|
| 2013 |
Reil JC, Tardif JC, Ford I, Lloyd SM, O'Meara E, Komajda M, Borer JS, Tavazzi L, Swedberg K, Böhm M. Selective heart rate reduction with ivabradine unloads the left ventricle in heart failure patients. Journal of the American College of Cardiology. 62: 1977-85. PMID 23933545 DOI: 10.1016/J.Jacc.2013.07.027 |
0.358 |
|
| 2013 |
O'Meara E, Mielniczuk LM, Wells GA, deKemp RA, Klein R, Coyle D, Mc Ardle B, Paterson I, White JA, Arnold M, Friedrich MG, Larose E, Dick A, Chow B, Dennie C, ... ... Tardif JC, et al. Alternative Imaging Modalities in Ischemic Heart Failure (AIMI-HF) IMAGE HF Project I-A: study protocol for a randomized controlled trial. Trials. 14: 218. PMID 23866673 DOI: 10.1186/1745-6215-14-218 |
0.333 |
|
| 2013 |
Guiraud T, Gayda M, Juneau M, Bosquet L, Meyer P, Théberge-Julien G, Galinier M, Nozza A, Lambert J, Rhéaume E, Tardif JC, Nigam A. A single bout of high-intensity interval exercise does not increase endothelial or platelet microparticles in stable, physically fit men with coronary heart disease. The Canadian Journal of Cardiology. 29: 1285-91. PMID 23830290 DOI: 10.1016/J.Cjca.2013.03.024 |
0.333 |
|
| 2013 |
Huynh T, Kouz S, Yan AT, Yan A, Danchin N, O'Loughlin J, Loughlin JO, Schampaert E, Yan RT, Yan R, Rinfret S, Tardif JC, Eisenberg MJ, Afilalo M, Chong A, et al. Canada Acute Coronary Syndrome Risk Score: a new risk score for early prognostication in acute coronary syndromes. American Heart Journal. 166: 58-63. PMID 23816022 DOI: 10.1016/J.Ahj.2013.03.023 |
0.312 |
|
| 2013 |
Roubille F, Tardif J. Inflammation and the heart - prime time for new therapeutic approaches. Expert Opinion On Emerging Drugs. 18: 259-261. PMID 23790157 DOI: 10.1517/14728214.2013.811487 |
0.31 |
|
| 2013 |
Chauvet C, Crespo K, Shi Y, Gelinas D, Duval F, L'Heureux N, Nattel S, Tardif JC, Deng AY. Unique quantitative trait loci in synergy permanently improve diastolic dysfunction. The Canadian Journal of Cardiology. 29: 1302-9. PMID 23773896 DOI: 10.1016/J.Cjca.2013.03.012 |
0.31 |
|
| 2013 |
Althouse AD, Abbott JD, Sutton-Tyrrell K, Forker AD, Lombardero MS, Buitrón LV, Pena-Sing I, Tardif JC, Brooks MM. Favorable effects of insulin sensitizers pertinent to peripheral arterial disease in type 2 diabetes: results from the Bypass Angioplasty Revascularization Investigation 2 Diabetes (BARI 2D) trial. Diabetes Care. 36: 3269-75. PMID 23735723 DOI: 10.2337/Dc12-2265 |
0.318 |
|
| 2013 |
Roubille F, Lattuca B, Busseuil D, Leclercq F, Davy J, Rhéaume E, Tardif J. Is ivabradine suitable to control undesirable tachycardia induced by dobutamine in cardiogenic shock treatment Medical Hypotheses. 81: 202-206. PMID 23719030 DOI: 10.1016/J.Mehy.2013.05.002 |
0.358 |
|
| 2013 |
Roubille F, Prunier F, Barrère-Lemaire S, Leclercq F, Piot C, Kritikou EA, Rhéaume E, Busseuil D, Tardif JC. What is the role of erythropoietin in acute myocardial infarct? Bridging the gap between experimental models and clinical trials Cardiovascular Drugs and Therapy. 27: 315-331. PMID 23695774 DOI: 10.1007/S10557-013-6461-1 |
0.307 |
|
| 2013 |
Roubille F, Tardif J. New Therapeutic Targets in Cardiology Heart Failure and Arrhythmia: HCN Channels Circulation. 127: 1986-1996. PMID 23671179 DOI: 10.1161/Circulationaha.112.000145 |
0.34 |
|
| 2013 |
den Hoed M, Eijgelsheim M, Esko T, Brundel BJ, Peal DS, Evans DM, Nolte IM, Segrè AV, Holm H, Handsaker RE, Westra HJ, Johnson T, Isaacs A, Yang J, Lundby A, ... ... Tardif JC, et al. Identification of heart rate-associated loci and their effects on cardiac conduction and rhythm disorders. Nature Genetics. 45: 621-31. PMID 23583979 DOI: 10.1038/Ng.2610 |
0.339 |
|
| 2013 |
Schuetz GM, Schlattmann P, Achenbach S, Budoff M, Garcia MJ, Roehle R, Pontone G, Meijboom WB, Andreini D, Alkadhi H, Honoris L, Bettencourt N, Hausleiter J, Leschka S, Gerber BL, ... ... Tardif JC, et al. Individual patient data meta-analysis for the clinical assessment of coronary computed tomography angiography: protocol of the Collaborative Meta-Analysis of Cardiac CT (CoMe-CCT). Systematic Reviews. 2: 13. PMID 23414575 DOI: 10.1186/2046-4053-2-13 |
0.365 |
|
| 2013 |
Roubille F, Tardif J. Cardioprotection—Time to Take Into Account Clinical Complexity: The Case of Antiplatelet Agents Cardiovascular Drugs and Therapy. 27: 105-107. PMID 23354515 DOI: 10.1007/S10557-013-6443-3 |
0.315 |
|
| 2013 |
Gebhard C, Huard G, Kritikou EA, Tardif J. Apolipoprotein B Antisense Inhibition -Update on Mipomersen Current Pharmaceutical Design. 19: 3132-3142. PMID 23317401 DOI: 10.2174/13816128113199990312 |
0.312 |
|
| 2013 |
Roubille C, Martel-Pelletier J, Haraoui B, Tardif J, Pelletier J. Biologics and the cardiovascular system: a double-edged sword. Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry. 12: 68-82. PMID 23286291 DOI: 10.2174/1871523011312010009 |
0.312 |
|
| 2013 |
Merlet N, Busseuil D, Rheaume E, Tardif J. Cardiac consequences of anti-inflammatory drugs in experimental models. Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry. 12: 24-35. PMID 23286290 DOI: 10.2174/1871523011312010005 |
0.306 |
|
| 2013 |
Bissonnette R, Tardif J, Harel F, Pressacco J, Bolduc C, Guertin M. Effects of the tumor necrosis factor-α antagonist adalimumab on arterial inflammation assessed by positron emission tomography in patients with psoriasis: results of a randomized controlled trial. Circulation-Cardiovascular Imaging. 6: 83-90. PMID 23204039 DOI: 10.1161/Circimaging.112.975730 |
0.312 |
|
| 2013 |
Tardif J, Ponikowski P, Kahan T. Effects of ivabradine in patients with stable angina receiving beta-blockers according to baseline heart rate: an analysis of the ASSOCIATE study International Journal of Cardiology. 168: 789-794. PMID 23138014 DOI: 10.1016/J.Ijcard.2012.10.011 |
0.324 |
|
| 2013 |
Ferrari R, Abergel H, Ford I, Fox KM, Greenlaw N, Steg PG, Hu D, Tendera M, Tardif JC. Gender- and age-related differences in clinical presentation and management of outpatients with stable coronary artery disease. International Journal of Cardiology. 167: 2938-43. PMID 22985742 DOI: 10.1016/J.Ijcard.2012.08.013 |
0.346 |
|
| 2013 |
Henrard V, Ducharme A, Khairy P, Gisbert A, Roy D, Levesque S, Talajic M, Thibault B, Racine N, White M, Guerra PG, Tardif JC. Cardiac remodeling with rhythm versus rate control strategies for atrial fibrillation in patients with heart failure: insights from the AF-CHF echocardiographic sub-study. International Journal of Cardiology. 165: 430-6. PMID 21917326 DOI: 10.1016/J.Ijcard.2011.08.077 |
0.34 |
|
| 2012 |
McGowan MP, Tardif JC, Ceska R, Burgess LJ, Soran H, Gouni-Berthold I, Wagener G, Chasan-Taber S. Randomized, placebo-controlled trial of mipomersen in patients with severe hypercholesterolemia receiving maximally tolerated lipid-lowering therapy. Plos One. 7: e49006. PMID 23152839 DOI: 10.1371/Journal.Pone.0049006 |
0.314 |
|
| 2012 |
Abbott JD, Lombardero MS, Barsness GW, Pena-Sing I, Buitrón LV, Singh P, Woodhead G, Tardif JC, Kelsey SF. Ankle-brachial index and cardiovascular outcomes in the Bypass Angioplasty Revascularization Investigation 2 Diabetes trial. American Heart Journal. 164: 585-590.e4. PMID 23067918 DOI: 10.1016/J.Ahj.2012.06.017 |
0.376 |
|
| 2012 |
Heinonen TM, Aamer M, Marshall C, Black DM, Tardif JC. Cardiovascular biomarkers and surrogate end points: key initiatives and clinical trial challenges. Expert Review of Cardiovascular Therapy. 10: 989-94. PMID 23030288 DOI: 10.1586/Erc.12.84 |
0.313 |
|
| 2012 |
Duchatelle V, Kritikou EA, Tardif J. Clinical Value of Drugs Targeting Inflammation for the Management of Coronary Artery Disease Canadian Journal of Cardiology. 28: 678-686. PMID 22926034 DOI: 10.1016/J.Cjca.2012.05.003 |
0.373 |
|
| 2012 |
Beaudoin M, Lo KS, N'Diaye A, Rivas MA, Dubé MP, Laplante N, Phillips MS, Rioux JD, Tardif JC, Lettre G. Pooled DNA resequencing of 68 myocardial infarction candidate genes in French canadians. Circulation. Cardiovascular Genetics. 5: 547-54. PMID 22923420 DOI: 10.1161/Circgenetics.112.963165 |
0.338 |
|
| 2012 |
Steg PG, Greenlaw N, Tardif JC, Tendera M, Ford I, Kääb S, Abergel H, Fox KM, Ferrari R. Women and men with stable coronary artery disease have similar clinical outcomes: insights from the international prospective CLARIFY registry. European Heart Journal. 33: 2831-40. PMID 22922505 DOI: 10.1093/Eurheartj/Ehs289 |
0.301 |
|
| 2012 |
Rhainds D, Arsenault BJ, Brodeur MR, Tardif JC. An update on the clinical development of dalcetrapib (RO4607381), a cholesteryl ester transfer protein modulator that increases HDL cholesterol levels. Future Cardiology. 8: 513-31. PMID 22871191 DOI: 10.2217/Fca.12.25 |
0.32 |
|
| 2012 |
O'Meara E, Khairy P, Blanchet MC, de Denus S, Pedersen OD, Levesque S, Talajic M, Ducharme A, White M, Racine N, Rouleau JL, Tardif JC, Roy D. Mineralocorticoid receptor antagonists and cardiovascular mortality in patients with atrial fibrillation and left ventricular dysfunction: insights from the Atrial Fibrillation and Congestive Heart Failure Trial. Circulation. Heart Failure. 5: 586-93. PMID 22798522 DOI: 10.1161/Circheartfailure.111.965160 |
0.337 |
|
| 2012 |
Arsenault BJ, Kritikou EA, Tardif J. Regression of Atherosclerosis Current Cardiology Reports. 14: 443-449. PMID 22706914 DOI: 10.1007/S11886-012-0285-7 |
0.338 |
|
| 2012 |
Denault AY, Tardif JC, Mazer CD, Lambert J. Difficult and complex separation from cardiopulmonary bypass in high-risk cardiac surgical patients: a multicenter study. Journal of Cardiothoracic and Vascular Anesthesia. 26: 608-16. PMID 22578975 DOI: 10.1053/J.Jvca.2012.03.031 |
0.329 |
|
| 2012 |
Steg PG, Ferrari R, Ford I, Greenlaw N, Tardif JC, Tendera M, Abergel H, Fox KM. Heart rate and use of beta-blockers in stable outpatients with coronary artery disease. Plos One. 7: e36284. PMID 22570699 DOI: 10.1371/Journal.Pone.0036284 |
0.367 |
|
| 2012 |
Gayda M, Bourassa MG, Tardif J, Fortier A, Juneau M, Nigam A. Heart Rate Recovery After Exercise and Long-term Prognosis in Patients With Coronary Artery Disease Canadian Journal of Cardiology. 28: 201-207. PMID 22336522 DOI: 10.1016/J.Cjca.2011.12.004 |
0.385 |
|
| 2012 |
Arsenault BJ, Boekholdt SM, Tardif J, Kastelein JJP. De-risking the clinical development of cholesteryl ester transfer protein inhibitors: how much is good enough? European Heart Journal. 33: 1548-1550. PMID 22041551 DOI: 10.1093/Eurheartj/Ehr408 |
0.326 |
|
| 2012 |
Andrade J, Roy D, Wyse G, Tardif J, Talajic M, Leduc H, Tourigny J, Dubuc M, Rivard L, Guerra P, Thibault B, Macle L, Khairy P. 468 Baseline Heart Rate and Adverse Outcomes in Patients With Atrial Fibrillation: A Combined Affirm and AF-CHF Sub-Study Canadian Journal of Cardiology. 28. DOI: 10.1016/J.Cjca.2012.07.430 |
0.316 |
|
| 2011 |
Tardif J, O’Meara E, Komajda M, Böhm MC, Borer JS, Ford I, Tavazzi L, Swedberg K. Effects of selective heart rate reduction with ivabradine on left ventricular remodelling and function: results from the SHIFT echocardiography substudy European Heart Journal. 32: 2507-2515. PMID 21875858 DOI: 10.1093/Eurheartj/Ehr311 |
0.332 |
|
| 2011 |
Arking DE, Junttila MJ, Goyette P, Huertas-Vazquez A, Eijgelsheim M, Blom MT, Newton-Cheh C, Reinier K, Teodorescu C, Uy-Evanado A, Carter-Monroe N, Kaikkonen KS, Kortelainen ML, Boucher G, Lagacé C, ... ... Tardif JC, et al. Identification of a sudden cardiac death susceptibility locus at 2q24.2 through genome-wide association in European ancestry individuals. Plos Genetics. 7: e1002158. PMID 21738491 DOI: 10.1371/Journal.Pgen.1002158 |
0.311 |
|
| 2011 |
Forcillo J, Maltais S, Aubin MC, Shi YF, Carrier M, Tardif JC, Perrault LP. Atorvastatin worsens left ventricular diastolic dysfunction and endothelial dysfunction of epicardial coronary arteries in normocholesterolemic porcine with left ventricular hypertrophy. Journal of Cardiovascular Pharmacology. 58: 295-306. PMID 21697733 DOI: 10.1097/Fjc.0B013E3182244993 |
0.364 |
|
| 2011 |
Tardif JC, Lesage F, Harel F, Romeo P, Pressacco J. Imaging biomarkers in atherosclerosis trials. Circulation. Cardiovascular Imaging. 4: 319-33. PMID 21586743 DOI: 10.1161/Circimaging.110.962001 |
0.315 |
|
| 2011 |
Lauzier B, Vaillant F, Gélinas R, Bouchard B, Brownsey R, Thorin E, Tardif JC, Des Rosiers C. Ivabradine reduces heart rate while preserving metabolic fluxes and energy status of healthy normoxic working hearts. American Journal of Physiology. Heart and Circulatory Physiology. 300: H845-52. PMID 21257916 DOI: 10.1152/Ajpheart.01034.2010 |
0.32 |
|
| 2011 |
Tendera M, Talajic M, Robertson M, Tardif J, Ferrari R, Ford I, Steg PG, Fox K. Safety of ivabradine in patients with coronary artery disease and left ventricular systolic dysfunction (from the BEAUTIFUL Holter Substudy). American Journal of Cardiology. 107: 805-811. PMID 21247517 DOI: 10.1016/J.Amjcard.2010.10.065 |
0.383 |
|
| 2011 |
Kouz R, Kouz S, Schampaert E, Rinfret S, Tardif JC, Nguyen M, Eisenberg M, Harvey R, Afilalo M, Lauzon C, Dery JP, Mansour S, Huynh T. Effectiveness and safety of glycoprotein IIb/IIIa inhibitors in patients with myocardial infarction undergoing primary percutaneous coronary intervention: a meta-analysis of observational studies. International Journal of Cardiology. 153: 249-55. PMID 20971515 DOI: 10.1016/J.Ijcard.2010.08.019 |
0.341 |
|
| 2011 |
Garneau SY, Deschamps A, Couture P, Levesque S, Babin D, Lambert J, Tardif JC, Perrault LP, Denault AY. Preliminary experience in the use of preoperative echo-guided left stellate ganglion block in patients undergoing cardiac surgery. Journal of Cardiothoracic and Vascular Anesthesia. 25: 78-84. PMID 20580574 DOI: 10.1053/J.Jvca.2010.03.007 |
0.357 |
|
| 2011 |
Jiang BH, Nguyen QT, Tardif JC, Shi Y, Dupuis J. Single measurement of troponin T for early prediction of infarct size, congestive heart failure, and pulmonary hypertension in an animal model of myocardial infarction. Cardiovascular Pathology : the Official Journal of the Society For Cardiovascular Pathology. 20: e85-9. PMID 20537565 DOI: 10.1016/J.Carpath.2010.04.005 |
0.315 |
|
| 2011 |
Tardif J. Slowing heart rate with ivabradine: new treatment options European Heart Journal. 13. DOI: 10.1093/Eurheartj/Sur019 |
0.388 |
|
| 2011 |
Kouz R, Berry C, Rheaume E, Brand G, Kernaleguen A, Grégoire J, Ibrahim R, Lespérance J, L'Allier P, Noble S, Meyer P, Guertin M, Tardif J. The Number Of Very Early Endothelial Progenitor Cell Colonies Correlates With Atherosclerosis Burden In Acute Coronary Syndromes Journal of the American College of Cardiology. 57. DOI: 10.1016/S0735-1097(11)61550-7 |
0.302 |
|
| 2011 |
Kouz R, Rheaume E, Berry C, Kernaleguen A, Brand G, Grégoire J, Ibrahim R, Lespérance J, L'Allier P, Noble S, Meyer P, Guertin M, Tardif J. Circulating Vegf Concentrations Are Independently Predictive Of Coronary Artery Disease Severity Measured By Quantitative Coronary Angiography In Patients With Stable Angina Journal of the American College of Cardiology. 57. DOI: 10.1016/S0735-1097(11)61464-2 |
0.348 |
|
| 2011 |
Denus Sd, Phillps MS, Dubé M, Turgeon J, Lavoie J, Guertin M, O'Meara E, Ducharme A, Racine N, Tardif J, Rouleau J, White M. 510 Baseline characteristics, hemodynamic, clinical and biochemical response to candesartan in a prospective, multicenter pharmacogenomic study of heart failure patients already receiving an ace inhibitor Canadian Journal of Cardiology. 27. DOI: 10.1016/J.Cjca.2011.07.428 |
0.332 |
|
| 2011 |
Kouz R, Rheaume E, Berry C, Kernaleguen A, Brand G, Grégoire J, Ibrahim R, Lespérance J, L'Allier P, Noble S, Meyer P, Guertin M, Tardif J. 211 Circulating vegf concentrations are independently predictive of coronary artery disease severity measured by quantitative coronary angiography in patients with stable angina Canadian Journal of Cardiology. 27. DOI: 10.1016/J.Cjca.2011.07.151 |
0.348 |
|
| 2011 |
Kouz R, Berry C, Rheaume E, Brand G, Kernaleguen A, Grégoire J, Ibrahim R, Lespérance J, L'Allier P, Noble S, Meyer P, Guertin M, Tardif J. 210 The number of very early endothelial progenitor cell colonies correlates with atherosclerosis burden in acute coronary syndromes Canadian Journal of Cardiology. 27. DOI: 10.1016/J.Cjca.2011.07.150 |
0.302 |
|
| 2010 |
Busseuil D, Shi Y, Mecteau M, Brand G, Gillis MA, Thorin E, Asselin C, Roméo P, Leung TK, Latour JG, Des Rosiers C, Bouly M, Rhéaume E, Tardif JC. Heart rate reduction by ivabradine reduces diastolic dysfunction and cardiac fibrosis. Cardiology. 117: 234-42. PMID 21212673 DOI: 10.1159/000322905 |
0.312 |
|
| 2010 |
Kulik A, May MRL, Voisine P, Tardif J, DeLarochelliere R, Naidoo S, Wells GA, Mesana TG, Ruel M. Aspirin Plus Clopidogrel Versus Aspirin Alone After Coronary Artery Bypass Grafting The Clopidogrel After Surgery for Coronary Artery Disease (CASCADE) Trial Circulation. 122: 2680-2687. PMID 21135365 DOI: 10.1161/Circulationaha.110.978007 |
0.348 |
|
| 2010 |
Tardif J. Emerging high-density lipoprotein infusion therapies: fulfilling the promise of epidemiology? Journal of Clinical Lipidology. 4: 399-404. PMID 21122683 DOI: 10.1016/J.Jacl.2010.08.018 |
0.361 |
|
| 2010 |
Tardif JC, L'Allier PL, Grégoire J, Ibrahim R, McFadden G, Kostuk W, Knudtson M, Labinaz M, Waksman R, Pepine CJ, Macaulay C, Guertin MC, Lucas A. A randomized controlled, phase 2 trial of the viral serpin Serp-1 in patients with acute coronary syndromes undergoing percutaneous coronary intervention. Circulation. Cardiovascular Interventions. 3: 543-8. PMID 21062996 DOI: 10.1161/Circinterventions.110.953885 |
0.343 |
|
| 2010 |
El-Rayes M, Schampaert E, Tardif JC, Eisenberg MJ, Afilalo M, Kouz S, Lauzon C, Harvey R, Nguyen M, Kouz R, Dery JP, Mansour S, Van Kieu AM, Rinfret S, Huynh T. Safety and effectiveness of enoxaparin following fibrinolytic therapy: Results of the Acute Myocardial Infarction (AMI)-QUEBEC registry. The Canadian Journal of Cardiology. 26: 431-6. PMID 20931096 DOI: 10.1016/S0828-282X(10)70441-4 |
0.328 |
|
| 2010 |
Jiang BH, Tardif JC, Sauvageau S, Ducharme A, Shi Y, Martin JG, Dupuis J. Beneficial effects of atorvastatin on lung structural remodeling and function in ischemic heart failure. Journal of Cardiac Failure. 16: 679-88. PMID 20670847 DOI: 10.1016/J.Cardfail.2010.03.003 |
0.325 |
|
| 2010 |
Nguyen BK, Maltais S, Perrault LP, Tanguay JF, Tardif JC, Stevens LM, Borie M, Harel F, Mansour S, Noiseux N. Improved function and myocardial repair of infarcted heart by intracoronary injection of mesenchymal stem cell-derived growth factors. Journal of Cardiovascular Translational Research. 3: 547-58. PMID 20559784 DOI: 10.1007/S12265-010-9171-0 |
0.326 |
|
| 2010 |
Lablanche JM, Leone A, Merkely B, Morais J, Alonso J, Santini M, Eha J, Demil N, Licour M, Tardif JC. Comparison of the efficacy of rosuvastatin versus atorvastatin in reducing apolipoprotein B/apolipoprotein A-1 ratio in patients with acute coronary syndrome: Results of the CENTAURUS study Archives of Cardiovascular Diseases. 103: 160-169. PMID 20417447 DOI: 10.1016/J.Acvd.2010.01.005 |
0.316 |
|
| 2010 |
Borer JS, Tardif J. Efficacy of Ivabradine, a Selective If Inhibitor, in Patients With Chronic Stable Angina Pectoris and Diabetes Mellitus American Journal of Cardiology. 105: 29-35. PMID 20102886 DOI: 10.1016/J.Amjcard.2009.08.642 |
0.334 |
|
| 2010 |
Tardif J. Coronary artery disease in 2010 European Heart Journal. 12. DOI: 10.1093/Eurheartj/Suq014 |
0.38 |
|
| 2010 |
Abbott JD, Lombardero M, Barsness G, Pena-Sing I, Buitron L, Singh P, Woodhead G, Tardif J, Kelsey S. Peripheral Arterial Disease Status And Cardiovascular Outcomes In The Bypass Angioplasty Revascularization Investigation 2 Diabetes Trial Journal of the American College of Cardiology. 55. DOI: 10.1016/S0735-1097(10)61465-9 |
0.316 |
|
| 2010 |
Abbott JD, Lombardero M, Tardif J, Pena-Sing I, Buitron L, Singh P, Woodhead G, Barsness G, Kelsey S. Peripheral Arterial Disease Progression In The Bypass Angioplasty Revascularization Investigation 2 Diabetes Trial Journal of the American College of Cardiology. 55. DOI: 10.1016/S0735-1097(10)61463-5 |
0.301 |
|
| 2009 |
Schwartz GG, Olsson AG, Ballantyne CM, Barter PJ, Holme IM, Kallend D, Leiter LA, Leitersdorf E, McMurray JJ, Shah PK, Tardif JC, Chaitman BR, Duttlinger-Maddux R, Mathieson J. Rationale and design of the dal-OUTCOMES trial: efficacy and safety of dalcetrapib in patients with recent acute coronary syndrome. American Heart Journal. 158: 896-901.e3. PMID 19958854 DOI: 10.1016/J.Ahj.2009.09.017 |
0.378 |
|
| 2009 |
Ugolini P, Pressacco J, Lespérance J, Berry C, L'Allier PL, Ibrahim R, Grégoire J, Ouellet R, Heinonen T, Levesque S, Guertin MC, Tardif JC. Evaluation of coronary atheroma by 64-slice multidetector computed tomography: Comparison with intravascular ultrasound and angiography. The Canadian Journal of Cardiology. 25: 641-7. PMID 19898696 DOI: 10.1016/S0828-282X(09)70161-8 |
0.335 |
|
| 2009 |
Rodés-Cabau J, Tardif JC, Cossette M, Bertrand OF, Ibrahim R, Larose E, Grégoire J, L'allier PL, Guertin MC. Acute effects of statin therapy on coronary atherosclerosis following an acute coronary syndrome. The American Journal of Cardiology. 104: 750-7. PMID 19733706 DOI: 10.1016/J.Amjcard.2009.05.009 |
0.347 |
|
| 2009 |
Meyer P, Nigam A, Marcil M, Tardif JC. The therapeutic potential of high-density lipoprotein mimetic agents in coronary artery disease. Current Atherosclerosis Reports. 11: 329-33. PMID 19664374 DOI: 10.1007/S11883-009-0049-Z |
0.362 |
|
| 2009 |
Waxman S, Dixon SR, L'Allier P, Moses JW, Petersen JL, Cutlip D, Tardif JC, Nesto RW, Muller JE, Hendricks MJ, Sum ST, Gardner CM, Goldstein JA, Stone GW, Krucoff MW. In vivo validation of a catheter-based near-infrared spectroscopy system for detection of lipid core coronary plaques: initial results of the SPECTACL study. Jacc. Cardiovascular Imaging. 2: 858-68. PMID 19608137 DOI: 10.1016/J.Jcmg.2009.05.001 |
0.348 |
|
| 2009 |
Tardif J. Heart rate as a treatable cardiovascular risk factor. British Medical Bulletin. 90: 71-84. PMID 19474056 DOI: 10.1093/Bmb/Ldp016 |
0.421 |
|
| 2009 |
Tendera M, Borer JS, Tardif J. Efficacy of I(f) inhibition with ivabradine in different subpopulations with stable angina pectoris. The Cardiology. 114: 116-125. PMID 19468225 DOI: 10.1159/000219938 |
0.342 |
|
| 2009 |
Couture P, Denault AY, Shi Y, Deschamps A, Cossette M, Pellerin M, Tardif JC. Effects of anesthetic induction in patients with diastolic dysfunction | Les effets de l'induction de l'anesthésie chez les patients souffrant de dysfonction diastolique Canadian Journal of Anesthesia. 56: 357-365. PMID 19340494 DOI: 10.1007/S12630-009-9068-Z |
0.343 |
|
| 2009 |
Mukaddam-Daher S, Menaouar A, Paquette P, Jankowski M, Gutkowska J, Gillis M, Shi Y, Calderone A, Tardif J. Hemodynamic and Cardiac Effects of Chronic Eprosartan and Moxonidine Therapy in Stroke-Prone Spontaneously Hypertensive Rats Hypertension. 53: 775-781. PMID 19273740 DOI: 10.1161/Hypertensionaha.108.126524 |
0.312 |
|
| 2009 |
Tardif J, Heinonen T, Noble S. High-density lipoprotein/apolipoprotein A-I infusion therapy Current Atherosclerosis Reports. 11: 58-63. PMID 19080729 DOI: 10.1007/S11883-009-0009-7 |
0.333 |
|
| 2009 |
Turmel J, Sériès F, Boulet LP, Poirier P, Tardif JC, Rodés-Cabeau J, Larose E, Bertrand OF. Relationship between atherosclerosis and the sleep apnea syndrome: an intravascular ultrasound study. International Journal of Cardiology. 132: 203-9. PMID 18221805 DOI: 10.1016/J.Ijcard.2007.11.063 |
0.343 |
|
| 2009 |
Tardif J. Angiotensin-converting enzyme inhibitors and atherosclerotic plaque: a key role in the cardiovascular protection of patients with coronary artery disease European Heart Journal. 11. DOI: 10.1093/Eurheartj/Sup022 |
0.409 |
|
| 2009 |
Tardif J. Heart rate and atherosclerosis European Heart Journal. 11. DOI: 10.1093/Eurheartj/Sup018 |
0.392 |
|
| 2008 |
Nicholls SJ, Tuzcu EM, Brennan DM, Tardif J, Nissen SE. Cholesteryl Ester Transfer Protein Inhibition, High-Density Lipoprotein Raising, and Progression of Coronary Atherosclerosis Circulation. 118: 2506-14. PMID 19029466 DOI: 10.1161/Circulationaha.108.790733 |
0.307 |
|
| 2008 |
Paquet C, Deschamps A, Denault AY, Couture P, Carrier M, Babin D, Levesque S, Piquette D, Lambert J, Tardif JC. Baseline regional cerebral oxygen saturation correlates with left ventricular systolic and diastolic function. Journal of Cardiothoracic and Vascular Anesthesia. 22: 840-6. PMID 18834789 DOI: 10.1053/J.Jvca.2008.02.013 |
0.324 |
|
| 2008 |
Lablanche J, Danchin N, Farnier M, Tedgui A, Vicaut E, Alonso J, Crean P, Leone A, Morais J, Santini M, Licour M, Farah M, Tardif J. Effects of rosuvastatin and atorvastatin on the apolipoprotein B/apolipoprotein A-1 ratio in patients with an acute coronary syndrome: The CENTAURUS trial design. Archives of Cardiovascular Diseases. 101: 399-406. PMID 18809153 DOI: 10.1016/J.Acvd.2008.05.010 |
0.304 |
|
| 2008 |
Apullan FJ, Bourassa MG, Tardif J, Fortier A, Gayda M, Nigam A. Usefulness of self-reported leisure-time physical activity to predict long-term survival in patients with coronary heart disease. American Journal of Cardiology. 102: 375-379. PMID 18678290 DOI: 10.1016/J.Amjcard.2008.03.072 |
0.319 |
|
| 2008 |
Turmel J, Boulet LP, Series F, Poirier P, Tardif JC, Rodes-Cabau J, Larose E, Bertrand OF. Is there an association between coronary atherosclerosis and airway responsiveness? Acta Cardiologica. 63: 347-53. PMID 18664026 DOI: 10.2143/Ac.63.3.1020312 |
0.359 |
|
| 2008 |
Tardif J. Ivabradine: I(f) inhibition in the management of stable angina pectoris and other cardiovascular diseases. Drugs of Today. 44: 171-181. PMID 18536779 DOI: 10.1358/Dot.2008.44.1193864 |
0.361 |
|
| 2008 |
Tardif JC, McMurray JJ, Klug E, Small R, Schumi J, Choi J, Cooper J, Scott R, Lewis EF, L'Allier PL, Pfeffer MA. Effects of succinobucol (AGI-1067) after an acute coronary syndrome: a randomised, double-blind, placebo-controlled trial. Lancet (London, England). 371: 1761-8. PMID 18502300 DOI: 10.1016/S0140-6736(08)60763-1 |
0.383 |
|
| 2008 |
Arnold JM, Fitchett DH, Howlett JG, Lonn EM, Tardif JC. Resting heart rate: a modifiable prognostic indicator of cardiovascular risk and outcomes? The Canadian Journal of Cardiology. 24: 3A-8A. PMID 18437251 DOI: 10.1016/S0828-282X(08)71019-5 |
0.345 |
|
| 2008 |
Alexander JH, Emery RW, Carrier M, Ellis SJ, Mehta RH, Hasselblad V, Menasche P, Khalil A, Cote R, Bennett-Guerrero E, Mack MJ, Schuler G, Harrington RA, Tardif JC. Efficacy and safety of pyridoxal 5'-phosphate (MC-1) in high-risk patients undergoing coronary artery bypass graft surgery: the MEND-CABG II randomized clinical trial. Jama. 299: 1777-87. PMID 18381567 DOI: 10.1001/Jama.299.15.Joc80027 |
0.357 |
|
| 2008 |
Mehta RH, Alexander JH, Emery R, Ellis SJ, Hasselblad V, Khalil A, Carrier M, Harrington RA, Tardif JC. A randomized, double-blind, placebo-controlled, multicenter study to evaluate the cardioprotective effects of MC-1 in patients undergoing high-risk coronary artery bypass graft surgery: MC-1 to Eliminate Necrosis and Damage in Coronary Artery Bypass Graft Surgery Trial (MEND-CABG) II--study design and rationale. American Heart Journal. 155: 600-8. PMID 18371465 DOI: 10.1016/J.Ahj.2008.01.002 |
0.368 |
|
| 2008 |
Kawase Y, Ly HQ, Prunier F, Lebeche D, Shi Y, Jin H, Hadri L, Yoneyama R, Hoshino K, Takewa Y, Sakata S, Peluso R, Zsebo K, Gwathmey JK, Tardif JC, et al. Reversal of cardiac dysfunction after long-term expression of SERCA2a by gene transfer in a pre-clinical model of heart failure. Journal of the American College of Cardiology. 51: 1112-9. PMID 18342232 DOI: 10.1016/J.Jacc.2007.12.014 |
0.324 |
|
| 2008 |
de Denus S, Tardif JC, White M, Bourassa MG, Racine N, Levesque S, Ducharme A. Temporal variations in hematocrit values in patients with left ventricular dysfunction: Relationship with cause-specific mortality and morbidity and optimal monitoring - Further insights from SOLVD Canadian Journal of Cardiology. 24: 45-48. PMID 18209768 DOI: 10.1016/S0828-282X(08)70547-6 |
0.34 |
|
| 2008 |
Ballantyne CM, Raichlen JS, Cain VA, Nicholls SJ, Nissen SE, Erbel R, Tardif J, Brener SJ. Response to Letters Regarding Article, “Effect of Rosuvastatin Therapy on Coronary Artery Stenoses Assessed by Quantitative Coronary Angiography: A Study to Evaluate the Effect of Rosuvastatin on Intravascular Ultrasound–Derived Coronary Atheroma Burden” Circulation. 118. DOI: 10.1161/Circulationaha.108.806281 |
0.38 |
|
| 2008 |
Tardif J. The pivotal role of heart rate in clinical practice: from atherosclerosis to acute coronary syndrome European Heart Journal. 10. DOI: 10.1093/Eurheartj/Sun021 |
0.401 |
|
| 2007 |
Tardif J. Clinical Results of If Current Inhibition by Ivabradine Drugs. 67: 35-41. PMID 17999562 DOI: 10.2165/00003495-200767002-00005 |
0.38 |
|
| 2007 |
Nigam A, Bourassa MG, Fortier A, Guertin M, Tardif J. Fasting but not postprandial (postmeal) glycemia predicts the risk of death in subjects with coronary artery disease. Canadian Journal of Cardiology. 23: 873-878. PMID 17876378 DOI: 10.1016/S0828-282X(07)70842-5 |
0.371 |
|
| 2007 |
Burstein B, Maguy A, Clément R, Gosselin H, Poulin F, Ethier N, Tardif JC, Hébert TE, Calderone A, Nattel S. Effects of resveratrol (trans-3,5,4'-trihydroxystilbene) treatment on cardiac remodeling following myocardial infarction. The Journal of Pharmacology and Experimental Therapeutics. 323: 916-23. PMID 17875610 DOI: 10.1124/Jpet.107.127548 |
0.333 |
|
| 2007 |
Piquette D, Deschamps A, Bélisle S, Pellerin M, Levesque S, Tardif JC, Denault AY. Effect of intravenous nitroglycerin on cerebral saturation in high-risk cardiac surgery Canadian Journal of Anesthesia. 54: 718-727. PMID 17766739 DOI: 10.1007/Bf03026868 |
0.317 |
|
| 2007 |
Fox K, Borer JS, Camm AJ, Danchin N, Ferrari R, Sendon JLL, Steg PG, Tardif J, Tavazzi L, Tendera M. Resting heart rate in cardiovascular disease. Journal of the American College of Cardiology. 50: 823-830. PMID 17719466 DOI: 10.1016/J.Jacc.2007.04.079 |
0.39 |
|
| 2007 |
Couture P, Denault AY, Pellerin M, Tardif JC. Milrinone enhances systolic, but not diastolic function during coronary artery bypass grafting surgery. Canadian Journal of Anaesthesia = Journal Canadien D'AnesthéSie. 54: 509-22. PMID 17602036 DOI: 10.1007/Bf03022314 |
0.309 |
|
| 2007 |
Haddad F, Denault AY, Couture P, Cartier R, Pellerin M, Levesque S, Lambert J, Tardif JC. Right Ventricular Myocardial Performance Index Predicts Perioperative Mortality or Circulatory Failure in High-Risk Valvular Surgery Journal of the American Society of Echocardiography. 20: 1065-1072. PMID 17566702 DOI: 10.1016/J.Echo.2007.02.017 |
0.326 |
|
| 2007 |
Tardif J, Carrier M, Kandzari DE, Emery R, Cote R, Heinonen T, Zettler M, Hasselblad V, Guertin M, Harrington RA. Effects of pyridoxal-5'-phosphate (MC-1) in patients undergoing high-risk coronary artery bypass surgery: results of the MEND-CABG randomized study. The Journal of Thoracic and Cardiovascular Surgery. 133: 1604-1611. PMID 17532963 DOI: 10.1016/J.Jtcvs.2007.01.049 |
0.368 |
|
| 2007 |
Berry C, L'Allier PL, Grégoire J, Lespérance J, Levesque S, Ibrahim R, Tardif JC. Comparison of intravascular ultrasound and quantitative coronary angiography for the assessment of coronary artery disease progression. Circulation. 115: 1851-7. PMID 17389269 DOI: 10.1161/Circulationaha.106.655654 |
0.338 |
|
| 2007 |
Tardif JC, Grégoire J, L'Allier PL, Ibrahim R, Lespérance J, Heinonen TM, Kouz S, Berry C, Basser R, Lavoie MA, Guertin MC, Rodés-Cabau J. Effects of reconstituted high-density lipoprotein infusions on coronary atherosclerosis: a randomized controlled trial. Jama. 297: 1675-82. PMID 17387133 DOI: 10.1001/Jama.297.15.Jpc70004 |
0.373 |
|
| 2007 |
Berry C, Tardif J, Bourassa MG. Coronary Heart Disease in Patients With Diabetes: Part II: Recent Advances in Coronary Revascularization Journal of the American College of Cardiology. 49: 643-656. PMID 17291929 DOI: 10.1016/J.Jacc.2006.09.045 |
0.333 |
|
| 2007 |
Berry C, Tardif J, Bourassa MG. Coronary heart disease in patients with diabetes: part I: recent advances in prevention and noninvasive management. Journal of the American College of Cardiology. 49: 631-642. PMID 17291928 DOI: 10.1016/J.Jacc.2006.09.046 |
0.347 |
|
| 2007 |
Aubin MC, Gendron ME, Lebel V, Thorin E, Tardif JC, Carrier M, Perrault LP. Alterations in the endothelial G-protein coupled receptor pathway in epicardial arteries and subendocardial arterioles in compensated left ventricular hypertrophy. Basic Research in Cardiology. 102: 144-53. PMID 17006634 DOI: 10.1007/S00395-006-0626-Z |
0.34 |
|
| 2007 |
Tardif J, Talajic M. Perindopril and prevention of atrial fibrillation European Heart Journal. 9. DOI: 10.1093/Eurheartj/Sum035 |
0.317 |
|
| 2006 |
Osman R, L'Allier PL, Elgharib N, Tardif JC. Critical appraisal of C-reactive protein throughout the spectrum of cardiovascular disease. Vascular Health and Risk Management. 2: 221-37. PMID 17326329 DOI: 10.2147/Vhrm.2006.2.3.221 |
0.339 |
|
| 2006 |
de Denus S, Tardif JC, White M, Bourassa MG, Racine N, Levesque S, Ducharme A. Quantification of the risk and predictors of hyperkalemia in patients with left ventricular dysfunction. A retrospective analysis of the Studies of Left Ventricular Dysfunction (SOLVD) trials American Heart Journal. 152: 705-712. PMID 16996842 DOI: 10.1016/J.Ahj.2006.05.030 |
0.373 |
|
| 2006 |
Denault AY, Couture P, Buithieu J, Haddad F, Carrier M, Babin D, Levesque S, Tardif JC. Left and right ventricular diastolic dysfunction as predictors of difficult separation from cariodpulmonary bypass Canadian Journal of Anesthesia. 53: 1020-1029. PMID 16987858 DOI: 10.1007/Bf03022532 |
0.307 |
|
| 2006 |
White DE, Coutu P, Shi YF, Tardif JC, Nattel S, St Arnaud R, Dedhar S, Muller WJ. Targeted ablation of ILK from the murine heart results in dilated cardiomyopathy and spontaneous heart failure. Genes & Development. 20: 2355-60. PMID 16951252 DOI: 10.1101/Gad.1458906 |
0.308 |
|
| 2006 |
Tardif J. Prevention challenges: The era of atherosclerosis regression Canadian Journal of Cardiology. 22: 27. PMID 16929388 DOI: 10.1016/S0828-282X(06)70999-0 |
0.319 |
|
| 2006 |
Tardif J, Heinonen T. Can ACAT inhibition limit the progression of atherosclerosis in patients with coronary artery disease Nature Reviews Cardiology. 3: 366-367. PMID 16810171 DOI: 10.1038/Ncpcardio0599 |
0.352 |
|
| 2006 |
Denault AY, Chaput M, Couture P, Hébert Y, Haddad F, Tardif JC. Dynamic right ventricular outflow tract obstruction in cardiac surgery. The Journal of Thoracic and Cardiovascular Surgery. 132: 43-9. PMID 16798301 DOI: 10.1016/J.Jtcvs.2006.03.014 |
0.318 |
|
| 2006 |
Tardif JC, Grégoire J, L'Allier PL, Ibrahim R, Lavoie MA, LeMay M, Cohen E, Levesque S, Keller PF, Heinonen T, Guertin MC. Effect of atherosclerotic regression on total luminal size of coronary arteries as determined by intravascular ultrasound. The American Journal of Cardiology. 98: 23-7. PMID 16784914 DOI: 10.1016/J.Amjcard.2006.01.052 |
0.353 |
|
| 2006 |
Aubin M, Carrier M, Shi YF, Tardif J, Perrault LP. Role of probucol on endothelial dysfunction of epicardial coronary arteries associated with left ventricular hypertrophy. Journal of Cardiovascular Pharmacology. 47: 702-710. PMID 16775511 DOI: 10.1097/01.Fjc.0000211763.13894.87 |
0.336 |
|
| 2006 |
De Denus S, White M, Tardif JC, Bourassa MG, Racine N, Levesque S, Ducharme A. Temporal Increases in Subclinical Levels of Inflammation Are Associated With Adverse Clinical Outcomes in Patients With Left Ventricular Dysfunction Journal of Cardiac Failure. 12: 353-359. PMID 16762798 DOI: 10.1016/J.Cardfail.2006.02.014 |
0.35 |
|
| 2006 |
Shi Y, Denault AY, Couture P, Butnaru A, Carrier M, Tardif JC. Biventricular diastolic filling patterns after coronary artery bypass graft surgery Journal of Thoracic and Cardiovascular Surgery. 131. PMID 16678593 DOI: 10.1016/J.Jtcvs.2006.01.015 |
0.352 |
|
| 2006 |
Nissen SE, Nicholls SJ, Sipahi I, Libby P, Raichlen JS, Ballantyne CM, Davignon J, Erbel R, Fruchart JC, Tardif JC, Schoenhagen P, Crowe T, Cain V, Wolski K, Goormastic M, et al. Effect of very high-intensity statin therapy on regression of coronary atherosclerosis: the ASTEROID trial. Jama. 295: 1556-65. PMID 16533939 DOI: 10.1001/Jama.295.13.Jpc60002 |
0.353 |
|
| 2006 |
Tardif J. Antioxidants: The good, the bad and the ugly Canadian Journal of Cardiology. 22. PMID 16498514 DOI: 10.1016/S0828-282X(06)70988-6 |
0.35 |
|
| 2006 |
Tardif J. Cardiac investigation in patients with diabetes. Canadian Journal of Cardiology. 22. PMID 16485059 DOI: 10.1016/S0828-282X(06)70978-3 |
0.318 |
|
| 2006 |
Nigam A, Bourassa MG, Fortier A, Guertin M, Tardif J. The metabolic syndrome and its components and the long-term risk of death in patients with coronary heart disease. American Heart Journal. 151: 514-521. PMID 16442923 DOI: 10.1016/J.Ahj.2005.03.050 |
0.317 |
|
| 2006 |
Tardif J, Berry C. From coronary artery disease to heart failure: potential benefits of ivabradine European Heart Journal. 8. DOI: 10.1093/Eurheartj/Sul021 |
0.395 |
|
| 2006 |
Paquet C, Couture P, Carrier M, Tardif J, Denault AY. Cerebral oxygen saturation and left ventricular function Canadian Journal of Anaesthesia-Journal Canadien D Anesthesie. 53: 26417-26417. DOI: 10.1007/Bf03017020 |
0.316 |
|
| 2005 |
Rodés-Cabau J, Candell-Riera J, Angel J, León Gd, Pereztol O, Castell-Conesa J, Soto A, Anívarro I, Aguadé S, Vázquez M, Domingo E, Tardif J, Soler-Soler J. Relation of myocardial perfusion defects and nonsignificant coronary lesions by angiography with insights from intravascular ultrasound and coronary pressure measurements. American Journal of Cardiology. 96: 1621-1626. PMID 16360346 DOI: 10.1016/J.Amjcard.2005.07.077 |
0.352 |
|
| 2005 |
Carricart M, Denault AY, Couture P, Limoges P, Babin D, Levesque S, Fortier A, Pellerin M, Tardif JC, Buithieu J. Incidence and significance of abnormal hepatic venous Doppler flow velocities before cardiac surgery Journal of Cardiothoracic and Vascular Anesthesia. 19: 751-758. PMID 16326300 DOI: 10.1053/J.Jvca.2004.11.052 |
0.304 |
|
| 2005 |
Wagner M, Rindress D, Desjardins B, Meilleur MC, Ducharme A, Tardif JC. Economic impact of the reduced incidence of atrial fibrillation in patients with heart failure treated with enalapril. American Heart Journal. 150: 985. PMID 16290980 DOI: 10.1016/J.Ahj.2005.07.027 |
0.339 |
|
| 2005 |
Dupuis J, Tardif JC, Rouleau JL, Ricci J, Arnold M, Lonn E, Roux R, Title LM, Amyot R, Bonafede N, Woo A, Cannon CP. Intensity of lipid lowering with statins and brachial artery vascular endothelium reactivity after acute coronary syndromes (from the BRAVER Trial) American Journal of Cardiology. 96: 1207-1213. PMID 16253583 DOI: 10.1016/J.Amjcard.2005.06.057 |
0.348 |
|
| 2005 |
Diaz A, Bourassa MG, Guertin M, Tardif J. Long-term prognostic value of resting heart rate in patients with suspected or proven coronary artery disease European Heart Journal. 26: 967-974. PMID 15774493 DOI: 10.1093/Eurheartj/Ehi190 |
0.392 |
|
| 2005 |
Guédès A, Keller PF, L'Allier PL, Lespérance J, Grégoire J, Tardif JC. Long-term safety of intravascular ultrasound in nontransplant, nonintervened, atherosclerotic coronary arteries. Journal of the American College of Cardiology. 45: 559-64. PMID 15708704 DOI: 10.1016/J.Jacc.2004.10.063 |
0.354 |
|
| 2005 |
Tardif J. Antioxidants and atherosclerosis: emerging drug therapies. Current Atherosclerosis Reports. 7: 71-77. PMID 15683606 DOI: 10.1007/S11883-005-0078-1 |
0.358 |
|
| 2005 |
Tardif J. Ivabradine in clinical practice: benefits of If inhibition European Heart Journal. 7. DOI: 10.1093/Eurheartj/Sui047 |
0.337 |
|
| 2005 |
Tardif J, Diaz A, Bourassa MG. Heart rate reduction through lifestyle modification: reply European Heart Journal. 26: 1807-1807. DOI: 10.1093/Eurheartj/Ehi399 |
0.369 |
|
| 2005 |
Deleon G, Rodescabau J, Candellriera J, Aguadebruix S, Castellconesa J, Angel J, Soto A, Anivarro I, Tardif J, Solersoler J. Intravascular ultrasound and coronary pressure measurements in patients with scintigraphic myocardial ischemia and non-significant coronary lesions Journal of Nuclear Cardiology. 12. DOI: 10.1016/J.Nuclcard.2004.12.090 |
0.337 |
|
| 2004 |
Tardif JC, Grégoire J, L'Allier PL, Anderson TJ, Bertrand O, Reeves F, Title LM, Alfonso F, Schampaert E, Hassan A, McLain R, Pressler ML, Ibrahim R, Lespérance J, Blue J, et al. Effects of the acyl coenzyme A:cholesterol acyltransferase inhibitor avasimibe on human atherosclerotic lesions. Circulation. 110: 3372-7. PMID 15533865 DOI: 10.1161/01.Cir.0000147777.12010.Ef |
0.312 |
|
| 2004 |
Tardif J, Ducharme A, Yu H, Wogen J, Guertin M. Retrospective longitudinal cohort study comparing the effects of angiotensin-converting enzyme inhibitors and long-acting calcium channel blockers on total and cardiovascular mortality in patients with hypertension Clinical Therapeutics. 26: 1073-1083. PMID 15336472 DOI: 10.1016/S0149-2918(04)90179-8 |
0.337 |
|
| 2004 |
Chugh SK, Koppel J, Scott M, Shewchuk L, Goodhart D, Bonan R, Tardif JC, Worthley SG, DiMario C, Curtis MJ, Meredith IT, Anderson TJ. Coronary flow velocity reserve does not correlate with TIMI frame count in patients undergoing non-emergency percutaneous coronary intervention. Journal of the American College of Cardiology. 44: 778-82. PMID 15312858 DOI: 10.1016/J.Jacc.2004.05.048 |
0.356 |
|
| 2004 |
L'Allier PL, Ducharme A, Keller P, Yu H, Guertin M, Tardif J. Angiotensin-converting enzyme inhibition in hypertensive patients is associated with a reduction in the occurrence of atrial fibrillation. Journal of the American College of Cardiology. 44: 159-164. PMID 15234426 DOI: 10.1016/J.Jacc.2004.03.056 |
0.318 |
|
| 2004 |
Guédès A, Tardif J. Intravascular ultrasound assessment of atherosclerosis. Current Atherosclerosis Reports. 6: 219-224. PMID 15068747 DOI: 10.1007/S11883-004-0035-4 |
0.344 |
|
| 2004 |
Cha TJ, Ehrlich JR, Zhang L, Shi YF, Tardif JC, Leung TK, Nattel S. Dissociation between ionic remodeling and ability to sustain atrial fibrillation during recovery from experimental congestive heart failure. Circulation. 109: 412-8. PMID 14718405 DOI: 10.1161/01.Cir.0000109501.47603.0C |
0.305 |
|
| 2004 |
Tardif J, Gregoire J, Lesperance J, Rodes J, Anderson T, Cohen E, Bertrand O, Lemay M, Alfonso F, Reeves F, Title L, Hassan A, McLain R, Pressler M, L'Allier PL. 882-2 Effects of avasimibe on coronary atherosclerosis assessed by intravascular ultrasound Journal of the American College of Cardiology. 43. DOI: 10.1016/S0735-1097(04)92244-9 |
0.33 |
|
| 2003 |
Tardif JC, Grégoire J, Lavoie MA, L'Allier PL. Vascular protectants for the treatment of atherosclerosis. Expert Review of Cardiovascular Therapy. 1: 385-92. PMID 15030266 DOI: 10.1586/14779072.1.3.385 |
0.322 |
|
| 2003 |
Tardif JC, Grégoire J, Lavoie MA, L'Allier PL. Pharmacologic prevention of both restenosis and atherosclerosis progression: AGI-1067, probucol, statins, folic acid and other therapies. Current Opinion in Lipidology. 14: 615-20. PMID 14624139 DOI: 10.1097/00041433-200312000-00010 |
0.356 |
|
| 2003 |
Nigam A, Mitchell GF, Lambert J, Tardif J. Relation between conduit vessel stiffness (assessed by tonometry) and endothelial function (assessed by flow-mediated dilatation) in patients with and without coronary heart disease. American Journal of Cardiology. 92: 395-399. PMID 12914868 DOI: 10.1016/S0002-9149(03)00656-8 |
0.344 |
|
| 2003 |
Malo O, Desjardins F, Tanguay J, Tardif J, Carrier M, Perrault LP. Tetrahydrobiopterin and antioxidants reverse the coronary endothelial dysfunction associated with left ventricular hypertrophy in a porcine model. Cardiovascular Research. 59: 501-511. PMID 12909333 DOI: 10.1016/S0008-6363(03)00390-0 |
0.369 |
|
| 2003 |
Malo O, Carrier M, Shi YF, Tardif J, Tanguay J, Perrault LP. Specific alterations of endothelial signal transduction pathways of porcine epicardial coronary arteries in left ventricular hypertrophy. Journal of Cardiovascular Pharmacology. 42: 275-286. PMID 12883333 DOI: 10.1097/00005344-200308000-00018 |
0.367 |
|
| 2003 |
Vermes E, Tardif JC, Bourassa MG, Racine N, Levesque S, White M, Guerra PG, Ducharme A. Enalapril decreases the incidence of atrial fibrillation in patients with left ventricular dysfunction: Insight from the studies of left ventricular dysfunction (SOLVD) trials Circulation. 107: 2926-2931. PMID 12771010 DOI: 10.1161/01.Cir.0000072793.81076.D4 |
0.368 |
|
| 2003 |
Larose E, Tardif J, Bourassa MG. Use of ACE Inhibitors for Secondary Prevention. Current Treatment Options in Cardiovascular Medicine. 5: 51-61. PMID 12686018 DOI: 10.1007/S11936-003-0014-Z |
0.395 |
|
| 2003 |
Tardif J. Clinical results with AGI-1067: a novel antioxidant vascular protectant American Journal of Cardiology. 91: 41-49. PMID 12645643 DOI: 10.1016/S0002-9149(02)03149-1 |
0.379 |
|
| 2003 |
Vermes E, Ducharme A, Bourassa MG, Lessard M, White M, Tardif J. Enalapril Reduces the Incidence of Diabetes in Patients With Chronic Heart Failure: Insight From the Studies Of Left Ventricular Dysfunction (SOLVD) Circulation. 107: 1291-1296. PMID 12628950 DOI: 10.1161/01.Cir.0000054611.89228.92 |
0.312 |
|
| 2003 |
Bourassa MG, Butnaru A, Lespérance J, Tardif J. Symptomatic myocardial bridges: overview of ischemic mechanisms and current diagnostic and treatment strategies. Journal of the American College of Cardiology. 41: 351-359. PMID 12575960 DOI: 10.1016/S0735-1097(02)02768-7 |
0.352 |
|
| 2003 |
Tardif JC, Grégoire J, Schwartz L, Title L, Laramée L, Reeves F, Lespérance J, Bourassa MG, L'Allier PL, Glass M, Lambert J, Guertin MC. Effects of AGI-1067 and probucol after percutaneous coronary interventions. Circulation. 107: 552-8. PMID 12566365 DOI: 10.1161/01.Cir.0000047525.58618.3C |
0.336 |
|
| 2002 |
Tardif JC, Grégoire J, Lespérance J, Lambert J, L'Allier PL, Rodés J, Anderson T, Blue JW, Imus J, Heinonen T. Design features of the Avasimibe and Progression of coronary Lesions assessed by intravascular UltraSound (A-PLUS) clinical trial. American Heart Journal. 144: 589-96. PMID 12360153 DOI: 10.1067/Mhj.2002.125329 |
0.398 |
|
| 2002 |
Meerkin D, Joyal M, Tardif JC, Lespérance J, Arsenault A, Lucier G, Bonan R. Two-year angiographic follow-up of intracoronary Sr90 therapy for restenosis prevention after balloon angioplasty. Circulation. 106: 539-43. PMID 12147533 DOI: 10.1161/01.Cir.0000023897.49599.6A |
0.337 |
|
| 2002 |
Shi Y, Li D, Tardif J, Nattel S. Enalapril effects on atrial remodeling and atrial fibrillation in experimental congestive heart failure. Cardiovascular Research. 54: 456-461. PMID 12062350 DOI: 10.1016/S0008-6363(02)00243-2 |
0.311 |
|
| 2002 |
Shinagawa K, Shi YF, Tardif JC, Leung TK, Nattel S. Dynamic nature of atrial fibrillation substrate during development and reversal of heart failure in dogs. Circulation. 105: 2672-8. PMID 12045175 DOI: 10.1161/01.Cir.0000016826.62813.F5 |
0.303 |
|
| 2002 |
Lattik R, Couture P, Denault AY, Carrier M, Harel F, Taillefer J, Tardif JC. Mitral Doppler indices are superior to two-dimensional echocardiographic and hemodynamic variables in predicting responsiveness of cardiac output to a rapid intravenous infusion of colloid Anesthesia and Analgesia. 94: 1092-1099. PMID 11973168 DOI: 10.1097/00000539-200205000-00007 |
0.336 |
|
| 2001 |
Tardif JC, Grégoire J. Antioxidants and prevention of restenosis after directional coronary atherectomy. Circulation. 103: E51-2. PMID 11222492 DOI: 10.1161/01.Cir.103.8.E51 |
0.328 |
|
| 2000 |
Tardif JC, Bertrand OF, Mongrain R, Lespérance J, Grégoire J, Paiement P, Bonan R. Reliability of mechanical and phased-array designs for serial intravascular ultrasound examinations--animal and clinical studies in stented and non-stented coronary arteries. International Journal of Cardiac Imaging. 16: 365-75. PMID 11215921 DOI: 10.1023/A:1026558824664 |
0.31 |
|
| 2000 |
Meerkin D, Tardif JC, Bertrand OF, Vincent J, Harel F, Bonan R. The effects of intracoronary brachytherapy on the natural history of postangioplasty dissections. Journal of the American College of Cardiology. 36: 59-64. PMID 10898413 DOI: 10.1016/S0735-1097(00)00678-1 |
0.339 |
|
| 2000 |
Doucet S, Malekianpour M, Théroux P, Bilodeau L, Côté G, de Guise P, Dupuis J, Joyal M, Gosselin G, Tanguay JF, Juneau M, Harel F, Nattel S, Tardif JC, Lespérance J. Randomized trial comparing intravenous nitroglycerin and heparin for treatment of unstable angina secondary to restenosis after coronary artery angioplasty. Circulation. 101: 955-61. PMID 10704160 DOI: 10.1161/01.Cir.101.9.955 |
0.352 |
|
| 1999 |
Malekianpour M, Rodés J, Côté G, Juneau M, Bonan R, Lespérance J, Couturier A, Tardif J. Value of exercise electrocardiography in the detection of restenosis after coronary angioplasty in patients with one-vessel disease American Journal of Cardiology. 84: 258-263. PMID 10496432 DOI: 10.1016/S0002-9149(99)00273-8 |
0.343 |
|
| 1999 |
Dupuis J, Tardif JC, Cernacek P, Théroux P. Cholesterol reduction rapidly improves endothelial function after acute coronary syndromes. The RECIFE (reduction of cholesterol in ischemia and function of the endothelium) trial. Circulation. 99: 3227-33. PMID 10385495 DOI: 10.1161/01.Cir.99.25.3227 |
0.338 |
|
| 1999 |
Meerkin D, Tardif JC, Crocker IR, Arsenault A, Joyal M, Lucier G, King SB, Williams DO, Serruys PW, Bonan R. Effects of intracoronary beta-radiation therapy after coronary angioplasty: an intravascular ultrasound study. Circulation. 99: 1660-5. PMID 10190873 DOI: 10.1161/01.Cir.99.13.1660 |
0.329 |
|
| 1999 |
Côté G, Tardif J, Lespérance J, Lambert J, Bourassa M, Bonan R, Gosselin G, Joyal M, Tanguay J, Nattel S, Gallo R, Crépeau J. Effects of Probucol on Vascular Remodeling After Coronary Angioplasty Circulation. 99: 30-35. PMID 9884376 DOI: 10.1161/01.Cir.99.1.30 |
0.308 |
|
| 1998 |
Poirier NC, Ugolini P, Pellerin M, Petitclerc R, Tardif J. Transesophageal echocardiographic evaluation of perioperative coronary sinus trauma The Annals of Thoracic Surgery. 66: 573-575. PMID 9725416 DOI: 10.1016/S0003-4975(98)00537-2 |
0.332 |
|
| 1998 |
Bertrand OF, Mongrain R, Soualmi L, Rodés J, Tardif JC, Crépeau J, Bonan R. Development of coronary aneurysm after cutting balloon angioplasty: assessment by intracoronary ultrasound. Catheterization and Cardiovascular Diagnosis. 44: 449-52. PMID 9716216 DOI: 10.1002/(Sici)1097-0304(199808)44:4<449::Aid-Ccd20>3.0.Co;2-C |
0.301 |
|
| 1998 |
Rodés J, Côté G, Lespérance J, Bourassa MG, Doucet S, Bilodeau L, Bertrand OF, Harel F, Gallo R, Tardif JC. Prevention of restenosis after angioplasty in small coronary arteries with probucol. Circulation. 97: 429-36. PMID 9490236 DOI: 10.1161/01.Cir.97.5.429 |
0.372 |
|
| 1996 |
Tardif J, Juneau M. Predicting ischaemic events in the perioperative period: in search of the perfect tool Canadian Journal of Anaesthesia-Journal Canadien D Anesthesie. 43: 989-994. PMID 8896848 DOI: 10.1007/Bf03011898 |
0.369 |
|
| Show low-probability matches. |